[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":22},{"code":4,"data":5,"meta":17},"SUCCESS",{"id":6,"createTime":7,"updateTime":7,"relativeEntities":8,"slug":9,"properties":10,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":19,"manageAffiliations":20,"indexDatabases":21,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":11,"title":13},{"VOID":12},"1283081X",{"EN":14},"EMC - Ginecología-Obstetricia","PUBLISHER","PENDING",null,0,[],[],[],{"meta":23,"data":25},{"total":24},"233",[26,105,152,228,489,544,621,711,950,1008],{"id":27,"createTime":28,"updateTime":29,"relativeEntities":30,"slug":31,"properties":32,"entityType":39,"verifyStatus":40,"verifyTime":29,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":42,"fullTextUrl":17,"authors":43,"publicationType":87,"publisherRelationship":88,"citationCount":17,"citationInfo":17,"publishDate":102,"publishYear":103,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"b01aff45-1715-4944-8358-bf5ecf6e69ef","2024-01-12T04:08:28.664+00:00","2024-12-05T23:50:18.874+00:00",[],"Recidiva-locorregional-del-c%C3%A1ncer-de-mama",{"references":33,"title":35,"doi":37},{"VOID":34},"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. 2019. https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaineentre-1990-et-2018-volume-1-tumeurs-solides-etud.\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies: incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nClemons, 2001, Locoregionally recurrent breast cancer: incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer: results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for earlystage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nMannino, 2009, Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?, Radiotherapy and Oncology, 90, 14, 10.1016\u002Fj.radonc.2008.05.002\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and Doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nMeattini, 2017, Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: long-term experience from two large-institutional series, Breast, 33, 139, 10.1016\u002Fj.breast.2017.03.017\nTay, 2020, Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors, Breast J, 26, 937, 10.1111\u002Ftbj.13738\nWu, 2020, Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ, Ann Surg Oncol, 27, 1627, 10.1245\u002Fs10434-019-08184-z\nMarinovich, 2016, The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 23, 3811, 10.1245\u002Fs10434-016-5446-2\nSigal-Zafrani, 2004, Histological margin assessment for breast ductal carcinoma in situ: precision and implications, Mod Pathol, 17, 81, 10.1038\u002Fmodpathol.3800019\nvan la Parra, 2019, Oncoplastic level 2 mammoplasty for large DCIS: 5-year results, Ann Surg Oncol, 26, 2459, 10.1245\u002Fs10434-019-07423-7\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a followup study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nKimberly, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year followup of a randomised, controlled phase 3 trial, Lancet Oncol, 19, 1385, 10.1016\u002FS1470-2045(18)30380-2\nde Boniface, 2017, Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 17, 379, 10.1186\u002Fs12885-017-3361-y\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is ‘young’?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWapnir, 2018, Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial, J Clin Oncol, 36, 1073, 10.1200\u002FJCO.2017.76.5719\nPan, 2017, 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years, N Engl J Med, 377, 1836, 10.1056\u002FNEJMoa1701830\nLowery, 2012, Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype, Breast Cancer Res Treat, 133, 831, 10.1007\u002Fs10549-011-1891-6\nZumsteg, 2013, Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer, Ann Surg Oncol, 20, 3469, 10.1245\u002Fs10434-013-3011-9\nChen, 2017, Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv Radiat Oncol, 2, 105, 10.1016\u002Fj.adro.2017.01.012\nWang, 2010, Triplenegative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nMamounas, 2010, Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20, J Clin Oncol, 28, 1677, 10.1200\u002FJCO.2009.23.7610\nMamounas, 2017, 21-Gene recurrence score and locoregional recurrence in nodepositive\u002Fer-positive breast cancer treated with chemo-endocrine therapy, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjw259\nTurashvili, 2017, 21-Gene recurrence score and locoregional recurrence in lymph nodenegative, estrogen receptor-positive breast cancer, Breast Cancer Res Treat, 166, 69, 10.1007\u002Fs10549-017-4381-7\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nAziz, 2006, The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer, Breast J, 12, 331, 10.1111\u002Fj.1075-122X.2006.00271.x\nChagpar, 2004, Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique, Am J Surg, 188, 399, 10.1016\u002Fj.amjsurg.2004.06.020\nMoore, 2000, Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy, Ann Surg, 231, 877, 10.1097\u002F00000658-200006000-00012\nvan Deurzen, 2016, Predictors of surgical margin following breastconserving surgery: a large population-based cohort study, Ann Surg Oncol, 23, 627, 10.1245\u002Fs10434-016-5532-5\nPleijhuis, 2013, A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making, Breast, 22, 773, 10.1016\u002Fj.breast.2013.01.010\nHeil, 2012, Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study, Ann Surg Oncol, 19, 541, 10.1245\u002Fs10434-011-1947-1\nGagliato Dde, 2014, Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer, J Clin Oncol, 32, 735, 10.1200\u002FJCO.2013.49.7693\nHennigs, 2016, Do patients after reexcision due to involved or close margins have the same risk of local recurrence as those after one-step breast-conserving surgery?, Ann Surg Oncol, 23, 1831, 10.1245\u002Fs10434-015-5067-1\nHolland, 1985, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer, 56, 979, 10.1002\u002F1097-0142(19850901)56:5\u003C979::AID-CNCR2820560502>3.0.CO;2-N\nFitzgerald, 2016, Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery, Ann Surg Oncol, 23, 4270, 10.1245\u002Fs10434-016-5490-y\nGarvey, 2015, Rates of residual disease with close but negative margins in breast cancer surgery, Breast, 24, 413, 10.1016\u002Fj.breast.2015.03.005\nDemirci, 2012, Breast conservation therapy: the influence of molecular subtype and margins, Int J Radiation Oncol Biol Physics, 83, 814, 10.1016\u002Fj.ijrobp.2011.09.001\nJones, 2009, Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial, J Clin Oncol, 27, 4939, 10.1200\u002FJCO.2008.21.5764\nHoussami, 2014, The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 21, 717, 10.1245\u002Fs10434-014-3480-5\nMoran, 2014, Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer, J Clin Oncol, 32, 1507, 10.1200\u002FJCO.2013.53.3935\nVaidya, 2020, Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial, BMJ, 370\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nBroecker, 2017, Neoadjuvant therapy combined with oncoplastic reduction for high-stage breast cancer patients, Ann Plast Surg, 78, S258, 10.1097\u002FSAP.0000000000001062\nMazouni, 2013, The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy, Breast, 22, 1189, 10.1016\u002Fj.breast.2013.07.055\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Cancer, 27, 240\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local recurrence after breast conservation (BORST), Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nSellam, 2019, Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment, Breast J, 25, 619, 10.1111\u002Ftbj.13290\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nHannoun-Levi, 2011, Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction, Brachytherapy, 10, 171, 10.1016\u002Fj.brachy.2010.05.004\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy. a second chance to preserve the breast1, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nVavassori, 2020, High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study, J Contemp Brachytherapy, 12, 207, 10.5114\u002Fjcb.2020.96860\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nMaaskant-Braat, 2013, Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature, Breast Cancer Res Treat, 138, 13, 10.1007\u002Fs10549-013-2409-1\nVugts, 2015, Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer, Ann Surg Oncol, 22, S529, 10.1245\u002Fs10434-015-4787-6\nVugts, 2015, Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer, Breast Cancer Res Treat, 153, 549, 10.1007\u002Fs10549-015-3571-4\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nRauschecker, 2001, Systemic therapy for treating locoregional recurrence in women with breast cancer, Cochrane Database Syst Rev, CD002195\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347",{"ES":36},"Recidiva locorregional del cáncer de mama",{"VOID":38},"10.1016\u002Fs1283-081x(22)46718-x","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2246718X",[44,62,74],{"id":45,"sortIndex":46,"researcher":17,"roles":47,"affiliations":49,"properties":59},"5635d257-5426-4a90-918d-397a90d7f98a",1,[48],"AUTHOR",[50],{"id":17,"sortIndex":18,"affiliation":51,"properties":17},{"id":52,"createTime":53,"updateTime":53,"relativeEntities":54,"slug":17,"properties":55,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"a40fbfc9-f226-4942-b18d-08639538be21","2024-01-12T04:08:28.851+00:00",[],{"title":56},{"VI":57},"Département de chirurgie oncologique, ICM Val d’Aurelle, rue de la Croix-Verte, 34298 Montpellier, France","AFFILIATION",{"title":60},{"VI":61},"C. Taoum",{"id":63,"sortIndex":18,"researcher":17,"roles":64,"affiliations":65,"properties":71},"088b5668-ccf2-4ccc-9e1f-710a39ebbf98",[48],[66],{"id":17,"sortIndex":18,"affiliation":67,"properties":17},{"id":52,"createTime":53,"updateTime":53,"relativeEntities":68,"slug":17,"properties":69,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":70},{"VI":57},{"title":72},{"VI":73},"P.-E. Colombo",{"id":75,"sortIndex":76,"researcher":17,"roles":77,"affiliations":78,"properties":84},"997809e6-5134-4187-8c55-2df934ca2a6c",2,[48],[79],{"id":17,"sortIndex":18,"affiliation":80,"properties":17},{"id":52,"createTime":53,"updateTime":53,"relativeEntities":81,"slug":17,"properties":82,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":83},{"VI":57},{"title":85},{"VI":86},"P. Rouanet","ARTICLE",{"url":42,"publisher":89,"properties":97},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":90,"slug":9,"properties":91,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":94,"manageAffiliations":95,"indexDatabases":96,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":92,"title":93},{"VOID":12},{"EN":14},[],[],[],{"volume":98,"pages":100},{"VOID":99},"58",{"VOID":101},"1-20","2022-07-01",2022,false,{"id":106,"createTime":107,"updateTime":108,"relativeEntities":109,"slug":110,"properties":111,"entityType":39,"verifyStatus":40,"verifyTime":108,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":117,"fullTextUrl":17,"authors":118,"publicationType":87,"publisherRelationship":136,"citationCount":17,"citationInfo":17,"publishDate":150,"publishYear":151,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"0f587774-e313-4f47-8240-920d2465b016","2023-12-11T19:26:25.287+00:00","2024-10-09T23:45:56.374+00:00",[],"Cervicitis",{"references":112,"title":114,"doi":115},{"VOID":113},"Brunham, 1984, Mucopurulent cervicitis – The ignored counterpart in women of urethritis in men, N Engl J Med, 311, 1, 10.1056\u002FNEJM198407053110101\nMarrazzo, 2002, Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis, Obstet Gynecol, 100, 579\nManhart, 2003, Mucopurulent cervicitis and Mycoplasma genitalium, J Infect Dis, 187, 650, 10.1086\u002F367992\nTaylor, 2013, Prevalence and treatment outcome of cervicitis of unknown etiology, Sex Transm Dis, 40, 379, 10.1097\u002FOLQ.0b013e31828bfcb1\nRyan, 1998, Risk assessment, symptoms and signs as predictors of vulvovaginal and cervical infections in urban US. STD clinic: implications for use of STD algorithms, Sex Transm Infect, 74, S59\nWilmott, 1988, Mucopurulent cervicitis: a clinical entity, Genitourin Med, 64, 169\nGaydos, 2009, Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted diseases clinics, Sex Transm Dis, 36, 598, 10.1097\u002FOLQ.0b013e3181b01948\nRandjelovic, 2018, The role of polymorphonuclear leukocyte counts from urethra, cervix, and vaginal wet mount in diagnosis of nongonococcal lower genital tract infection, Infect Dis Obstet Gynecol, 2018, 8236575, 10.1155\u002F2018\u002F8236575\nMeena, 2016, Study to evaluate targeted management and syndromic management in women presenting with abnormal vaginal discharge, J Obstet Gynaecol India, 66, 534, 10.1007\u002Fs13224-016-0879-x\nWorkowski, 2018, Syphilis elimination: lessons learned again, Sex Transm Dis, 45, S80\nFarrukh, 2018, The additive value of pelvic examinations to history in predicting sexually transmitted infections for young female patients with suspected cervicitis or pelvic inflammatory disease, Ann Emerg Med, 72, 10.1016\u002Fj.annemergmed.2018.05.004\nFalk, 2010, The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of Chlamydia infection, Acta Derm Venereol, 90, 506, 10.2340\u002F00015555-0924\nLusk, 2016, Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics, Sex Transm Infect, 92, 175, 10.1136\u002Fsextrans-2015-052332\nWira, 2014, Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens, Am J Reprod Immunol, 72, 236, 10.1111\u002Faji.12252\nThompson, 1992, The leukocytic reaction of the human uterine cervix, Am J Reprod Immunol, 28, 85, 10.1111\u002Fj.1600-0897.1992.tb00765.x\nSuarez, 2006, Sperm transport in the female reproductive tract, Hum Reprod Update, 12, 23, 10.1093\u002Fhumupd\u002Fdmi047\nWorkowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. https:\u002F\u002Fwww.cdc.gov\u002Fstd\u002Ftg2015\u002Ftg-2015-print.pdf.\nPellati, 2008, Genital tract infections infertility, Eur J Obstet Gynecol Reprod Biol, 140, 3, 10.1016\u002Fj.ejogrb.2008.03.009\nCina, 2019, Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis, Sex Transm Infect, 95, 328, 10.1136\u002Fsextrans-2018-053823\nCastle, 2001, An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV), Cancer Epidemiol Biomarkers Prev, 10, 1021\nCastle, 2004, Beyond Human Papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer, J Low Genit Tract Dis, 8, 224, 10.1097\u002F00128360-200407000-00011\nNugent, 1992, Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. the investigators of the Johns Hopkins Study of cervicitis and adverse pregnancy outcome, Sex Transm Dis, 19, 198, 10.1097\u002F00007435-199207000-00003\nAhmadi, 2018, Association of Chlamydia trachomatis infections with preterm delivery; a systematic review and meta-analysis, BMC Pregnancy Childbirth, 18, 240, 10.1186\u002Fs12884-018-1868-0\nSelhorst, 2017, Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants, Clin Infect Dis, 64, 79, 10.1093\u002Fcid\u002Fciw663\nGaydos, 2006, 63\nMarrazzo, 2006, Risk factors of cervicitis among women with bacterial vaginosis, J Infect Dis, 193, 617, 10.1086\u002F500149\nRowley, 2019, Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016, Bull World Health Organ, 97, 548, 10.2471\u002FBLT.18.228486\nEstimations nationales et régionales du nombre de diagnostics d’infections à Chlamydia et à gonocoque en France en 2016. Saint-Maurice: Santé publique France; 2018. 6p. Disponible à partir de l’URL : www.santepubliquefrance.fr.\nHAS. Réévaluation de la stratégie de dépistage des infections à Chlamydia trachomatis, septembre 2018.\nPáez-Canro, 2019, Antibiotics for treating urogenital infection in men and non-pregnant women, Cochrane Database Syst Rev\nMohammadzadeh, 2019, Urogenital Chlamydia trachomatis treatment failure with azithromycin: a meta-analysis, Int J Reprod Biomed, 17, 603\nQuillin, 2018, Neisseria gonorrhoeae host adaptation and pathogenesis, Nat Rev Microbiol, 16, 226, 10.1038\u002Fnrmicro.2017.169\nCaumes, 2018, Infections sexuellement transmissibles (IST) : gonococcies, chlamydioses, syphilis, papillomavirus humains (HPV), trichomonose, N°158 UE6 ECNPilly\nWi, 2017, Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action, PLoS Med, 14, e1002344, 10.1371\u002Fjournal.pmed.1002344\nMlynarczyk-Bonikowska, 2018, Antibiotic resistance and NG-MAST sequence types of Neisseria gonorrhoeae isolates in Poland compared to the world, Postepy Dermatol Allergol, 35, 346\nTully, 1981, A newly discovered Mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nLis, 2015, Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis, Clin Infect Dis, 61, 418, 10.1093\u002Fcid\u002Fciv312\nWiesenfeld, 2017, Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen, J Infect Dis, 216, S389, 10.1093\u002Finfdis\u002Fjix198\nPereyre, 2017, Investigator group Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases, Clin Microbiol Infect, 23, 10.1016\u002Fj.cmi.2016.10.028\nSoni S, Horner P, Rayment M, Pinto-Sander N, Naous N. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018).\nDeguchi, 2016, Multidrug-resistant Mycoplasma genitalium is increasing, Clin Infect Dis, 62, 405, 10.1093\u002Fcid\u002Fciv898\nAntibiotiques de la famille des quinolones et fluoroquinolones administrés par voie systémique ou inhalée : risque d’effets indésirables invalidants, durables et potentiellement irréversibles et restrictions d’utilisation. Communiqué ANSM, avril 2019.\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nRead RH, Jensen JS, Grant ME. Efficacy of pristinamycin for treatment resistant Mycoplasma genitalium. In: Adelaide, Australia: Australasian Sexual Health Conference, 2010.\nWorkowski, 2015, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 64, 1\nFowotade, 2013, Apparent rarity of asymptomatic herpes cervicitis in a woman with intra-uterine contraceptive device, J Public Health Afr, 4, e14, 10.4081\u002Fjphia.2013.e14\nSingh, 1999, Biological behaviour and aetiology of inflammatory cervical smears, Diagn Cytopathol, 20, 199, 10.1002\u002F(SICI)1097-0339(199904)20:4\u003C199::AID-DC3>3.0.CO;2-2\nUusküla, 2004, Atypical genital herpes: report of five cases, Scand J Infect Dis, 36, 37, 10.1080\u002F00365540310017276\nViikki, 2000, Gynaecological infections as risk determinants of subsequent cervical neoplasia, Acta Oncol, 39, 71, 10.1080\u002F028418600431003\nChauhan, 2019, Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility, PLoS One, 14, e0220330, 10.1371\u002Fjournal.pone.0220330\nProkopakis, 2002, K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix, Oncol Rep, 9, 129\nMirzaie-Kashani, 2014, Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma. Jundishapur, J Microbiol, 7, e9930\nÉvaluation de la recherche des papilloma virus humains (HPV) en dépistage primaire des lésions précancéreuses et cancéreuses du col de l’utérus et de la place du double immuno-marquage p16\u002FKi67 HAS juillet 2019. www.has-sante.fr.\nDasari, 2010, Colposcopic evaluation of cervix with persistent inflammatory Pap smear: a prospective analytical study, Cytojournal, 7, 16, 10.4103\u002F1742-6413.67112\nIshimaru, 2019, Syphilitic cervicitis with cervical cancer presenting as oropharyngeal syphilis, Intern Med, 58, 2251, 10.2169\u002Finternalmedicine.2426-18\nZhu, 2015, Cervical syphilitic lesions mimicking cervical cancer: a rare case report, Int J Infect Dis, 31, 1, 10.1016\u002Fj.ijid.2014.12.005\nMitchell, 2017, Cervical ectropion may be a cause of desquamative inflammatory vaginitis, Sex Med, 5, e212, 10.1016\u002Fj.esxm.2017.03.001\nAgah, 2019, Cryotherapy as a method for relieving symptoms of cervical ectopy: a randomized clinical trial, Oman Med J, 34, 322, 10.5001\u002Fomj.2019.63\nWorkowski, 2015, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015 [published correction appears in MMWR Recomm Rep 2015 Aug 28;64:924], MMWR Recomm Rep, 64, 1\nHamoonga, 2019, Vaginal douching in Zambia: a risk or benefit to women in the fight against cervical cancer: a retrospective cohort study, BMC Womens Health, 19, 135, 10.1186\u002Fs12905-019-0834-y\nWilkinson, 2002, Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women, Lancet Infect Dis, 2, 613, 10.1016\u002FS1473-3099(02)00396-1\nLusk, 2017, Cervicitis: a prospective observational study of empiric azithromycin treatment in women with cervicitis and non-specific cervicitis, Int J STD AIDS, 28, 120, 10.1177\u002F0956462416628319\nPaavonen, 1989, Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin, Am J Obstet Gynecol, 161, 128, 10.1016\u002F0002-9378(89)90249-4\nSchwebke, 2002, Interrelationships of bacterial vaginosis and cervical inflammation, Sex Transm Dis, 29, 59, 10.1097\u002F00007435-200201000-00010\nDe Backer, 2006, Antibiotic susceptibility of Atopobium vaginae, BMC Infect Dis, 6, 51, 10.1186\u002F1471-2334-6-51",{"ES":110},{"VOID":116},"10.1016\u002Fs1283-081x(20)44040-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20440408",[119],{"id":120,"sortIndex":18,"researcher":17,"roles":121,"affiliations":122,"properties":133},"daed47f7-376b-4e0a-bcb4-ff3740707624",[48],[123],{"id":17,"sortIndex":18,"affiliation":124,"properties":17},{"id":125,"createTime":126,"updateTime":127,"relativeEntities":128,"slug":129,"properties":130,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":131},{"VI":132},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":134},{"VI":135},"J.-M. Bohbot",{"url":117,"publisher":137,"properties":145},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":138,"slug":9,"properties":139,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":142,"manageAffiliations":143,"indexDatabases":144,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":140,"title":141},{"VOID":12},{"EN":14},[],[],[],{"volume":146,"pages":148},{"VOID":147},"56",{"VOID":149},"1-6","2020-08-01",2020,{"id":153,"createTime":154,"updateTime":155,"relativeEntities":156,"slug":157,"properties":158,"entityType":39,"verifyStatus":40,"verifyTime":155,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":165,"fullTextUrl":17,"authors":166,"publicationType":87,"publisherRelationship":212,"citationCount":17,"citationInfo":17,"publishDate":226,"publishYear":227,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"94dcc4e8-63c8-48e3-849a-5017147480b4","2024-02-06T21:03:01.649+00:00","2024-12-07T23:44:38.605+00:00",[],"Hipertensi%C3%B3n-arterial-durante-el-embarazo-aspectos-fisiopatol%C3%B3gicos-y-pron%C3%B3stico-a-largo-plazo",{"references":159,"title":161,"doi":163},{"VOID":160},"Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126\u002Fscience.1111726\nSibai, 2005, Pre-eclampsia, Lancet, 365, 785, 10.1016\u002FS0140-6736(05)71003-5\nDavison, 2004, New aspects in the pathophysiology of preeclampsia, J. Am. Soc. Nephrol., 15, 2440, 10.1097\u002F01.ASN.0000135975.90889.60\n2000, Report of the national high blood pressure education program working group on high blood pressure in pregnancy, Am. J. Obstet. Gynecol., 183, S1, 10.1067\u002Fmob.2000.107928\nAardema, 2004, Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities?, Clin. Sci., 106, 377, 10.1042\u002FCS20030385\nVatten, 2004, Is pre-eclampsia more than one disease?, BJOG, 111, 298, 10.1111\u002Fj.1471-0528.2004.00071.x\nSaftlas, 1990, Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986, Am. J. Obstet. Gynecol., 163, 460, 10.1016\u002F0002-9378(90)91176-D\nZhang, 2003, Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States, Hypertens. Pregn., 22, 203, 10.1081\u002FPRG-120021066\nSibai, 1993, Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am. J. Obstet. Gynecol., 169, 1000, 10.1016\u002F0002-9378(93)90043-I\nCincotta, 1996, A review of eclampsia in Melbourne: 1978-1992, Aust. N. Z. J. Obstet. Gynaecol., 36, 264, 10.1111\u002Fj.1479-828X.1996.tb02707.x\nBeaufils, 1983, Hypertensions artérielles gravidiques et médecine préventive. Étude des facteurs étiologiques et du pronostic à moyen terme dans 442 cas, Bull. Acad. Natl. Med., 167, 413\nSibai, 1995, Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am. J. Obstet. Gynecol., 172, 642, 10.1016\u002F0002-9378(95)90586-3\nDuckitt, 2005, Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies, BMJ, 330, 565, 10.1136\u002Fbmj.38380.674340.E0\nConde-Agudelo, 1999, Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review, Am. J. Obstet. Gynecol., 181, 1026, 10.1016\u002FS0002-9378(99)70341-8\nZhang, 1999, The puzzling association between smoking and hypertension during pregnancy, Am. J. Obstet. Gynecol., 181, 1407, 10.1016\u002FS0002-9378(99)70384-4\nMaynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J. Clin. Invest., 111, 649, 10.1172\u002FJCI17189\nPowers, 2005, Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia, Am. J. Obstet. Gynecol., 193, 185, 10.1016\u002Fj.ajog.2004.11.038\nRobillard, 1994, Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception, Lancet, 344, 973, 10.1016\u002FS0140-6736(94)91638-1\nSmith, 1997, lncreased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility, Am. J. Obstet. Gynecol., 177, 455, 10.1016\u002FS0002-9378(97)70215-1\nKoelman, 2000, Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?, J. Reprod. Immunol., 46, 155, 10.1016\u002FS0165-0378(99)00062-5\nKlonoff-Cohen, 1989, An epidemiologic study of contraception and preeclampsia, JAMA, 262, 3143, 10.1001\u002Fjama.1989.03430220066032\nEinarsson, 2003, Sperm exposure and development of preeclampsia, Am. J. Obstet. Gynecol., 188, 1241, 10.1067\u002Fmob.2003.401\nWang, 2002, Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia, Lancet, 359, 673, 10.1016\u002FS0140-6736(02)07804-2\nRobertson, 2003, Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis, J. Reprod. Immunol., 59, 253, 10.1016\u002FS0165-0378(03)00052-4\nDekker, 1995, Underlying disorders associated with severe early-onset preeclampsia, Am. J. Obstet. Gynecol., 173, 1042, 10.1016\u002F0002-9378(95)91324-6\nKupferminc, 1999, Increased frequency of genetic thrombophilia in women with complications of pregnancy, N. Engl. J. Med., 340, 9, 10.1056\u002FNEJM199901073400102\nRey, 2003, Thrombophilic disorders and fetal loss: a meta-analysis, Lancet, 361, 901, 10.1016\u002FS0140-6736(03)12771-7\nLin, 2005, Genetic thrombophilias and preeclampsia: a meta-analysis, Obstet. Gynecol., 105, 182, 10.1097\u002F01.AOG.0000146250.85561.e9\n2005, Disentangling Fetal and Maternal Susceptibility for Pre-Eclampsia: A British Multicenter Candidate-Gene Study, Am. J. Hum. Genet., 77, 127, 10.1086\u002F431245\nCincotta, 1998, Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas, Int. J. Gynaecol. Obstet., 60, 23, 10.1016\u002FS0020-7292(97)00241-5\nArngrimsson, 1990, Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population, Br. J. Obstet. Gynaecol., 97, 762, 10.1111\u002Fj.1471-0528.1990.tb02569.x\nCnattingius, 2004, Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study, Am. J. Med. Genet., 130, 365, 10.1002\u002Fajmg.a.30257\nThornton, 1999, Twin mothers, pregnancy hypertension and pre-eclampsia, Br. J. Obstet. Gynaecol., 106, 570, 10.1111\u002Fj.1471-0528.1999.tb08326.x\nTreolar, 2001, An Australian twin study of the genetic basis of preeclampsia and eclampsia, Am. J. Obstet. Gynecol., 184, 374, 10.1067\u002Fmob.2001.109400\nSalonen, 2000, Genetic effects on the liability of developing pre-eclampsia and gestational hypertension, Am. J. Med. Genet., 91, 256, 10.1002\u002F(SICI)1096-8628(20000410)91:4\u003C256::AID-AJMG3>3.0.CO;2-T\nWard, 1993, A molecular variant of angiotensinogen associated with preeclampsia, Nat. Genet., 4, 59, 10.1038\u002Fng0593-59\nMorgan, 1999, Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua, Am. J. Obstet. Gynecol., 180, 95, 10.1016\u002FS0002-9378(99)70156-0\nArngrimsson, 1997, Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region, Am. J. Hum. Genet., 61, 354, 10.1086\u002F514843\nSavvidou, 2001, Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy, Hypertension, 38, 1289, 10.1161\u002Fhy1201.097305\nvan Dijk, 2005, Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family, Nat. Genet., 37, 514, 10.1038\u002Fng1541\nLie, 1998, Fetal and maternal contributions to risk of pre-eclampsia: population based study, BMJ, 316, 1343, 10.1136\u002Fbmj.316.7141.1343\nEsplin, 2001, Paternal and maternal components of the predisposition to preeclampsia, N. Engl. J. Med., 344, 867, 10.1056\u002FNEJM200103223441201\nSkjaerven, 2005, Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort, BMJ, 331, 877, 10.1136\u002Fbmj.38555.462685.8F\nDizon-Townson, 1997, Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction, Am. J. Obstet. Gynecol., 177, 402, 10.1016\u002FS0002-9378(97)70205-9\nAbitbol, 1977, Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone, Am. J. Pathol., 86, 573\nZhou, 1993, Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys, Am. J. Obstet. Gynecol., 169, 224, 10.1016\u002F0002-9378(93)90172-F\nFaas, 1994, A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats, Am. J. Obstet. Gynecol., 171, 158, 10.1016\u002F0002-9378(94)90463-4\nDavisson, 2002, Discovery of a spontaneous genetic mouse model of preeclampsia, Hypertension, 39, 337, 10.1161\u002Fhy02t2.102904\nDi Nicolantonio, 2000, Fetal versus maternal determinants of the reduced fetal and placental growth in spontaneously hypertensive rats, J. Hypertens., 18, 45, 10.1097\u002F00004872-200018010-00007\nTakimoto, 1996, Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen, Science, 274, 995, 10.1126\u002Fscience.274.5289.995\nBohlender, 2000, Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension, J. Am. Soc. Nephrol., 11, 2056, 10.1681\u002FASN.V11112056\nPiering, 1993, Preeclampsia related to a functioning extrauterine placenta: report of a case and 25-year follow-up, Am. J. Kidney Dis., 21, 310, 10.1016\u002FS0272-6386(12)80751-7\nCaniggia, 1997, Activin is a local regulator of human cytotrophoblast cell differentiation, Endocrinology, 138, 3976, 10.1210\u002Fen.138.9.3976\nZhou, 1997, Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?, J. Clin. Invest., 99, 2139, 10.1172\u002FJCI119387\nXia, 2002, Angiotensin II inhibits human trophoblast Invasion through AT1 Receptor Activation, J. Biol. Chem., 277, 24601, 10.1074\u002Fjbc.M201369200\nRajakumar, 2004, Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae, Placenta, 25, 763, 10.1016\u002Fj.placenta.2004.02.011\nRobertson, 1976, Maternal uterine vascular lesions in the hypertensive complications of pregnancy, Perspect. Nephrol. Hypertens., 5, 115\nKhong, 1986, Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants, Br. J. Obstet. Gynaecol., 93, 1049, 10.1111\u002Fj.1471-0528.1986.tb07830.x\nBrosens, 2002, The myometrial junctional zone spiral arteries in normal and abnormal pregnancies --A review of the literature, Am. J. Obstet. Gynecol., 187, 1416, 10.1067\u002Fmob.2002.127305\nParham, 2004, NK cells and trophoblasts: partners in pregnancy, J. Exp. Med., 200, 951, 10.1084\u002Fjem.20041783\nHiby, 2004, Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success, J. Exp. Med., 200, 957, 10.1084\u002Fjem.20041214\nYie, 2005, Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy, Am. J. Obstet. Gynecol., 193, 204, 10.1016\u002Fj.ajog.2004.11.062\nHylenius, 2004, Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads, Mol. Hum. Reprod., 10, 237, 10.1093\u002Fmolehr\u002Fgah035\nAgrawal, 2003, The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus, J. Hematother. Stem Cell Res., 12, 749, 10.1089\u002F15258160360732768\nTsatsaris, 2003, Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences, J. Clin. Endocrinol. Metab., 88, 5555, 10.1210\u002Fjc.2003-030528\nAhmad, 2004, Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia, Circul Res., 95, 884, 10.1161\u002F01.RES.0000147365.86159.f5\nZhou, 2002, Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome, Am. J. Pathol., 160, 1405, 10.1016\u002FS0002-9440(10)62567-9\nLevine, 2004, Circulating angiogenic factors and the risk of preeclampsia, N. Engl. J. Med., 350, 672, 10.1056\u002FNEJMoa031884\nLevine, 2005, Urinary placental growth factor and risk of preeclampsia, JAMA, 293, 77, 10.1001\u002Fjama.293.1.77\nHertig, 2004, Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia, Clin. Chem., 50, 1702, 10.1373\u002Fclinchem.2004.036715\nThadhani, 2004, First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia, J. Clin. Endocrinol. Metab., 89, 770, 10.1210\u002Fjc.2003-031244\nWolf, 2005, Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies, Am. J. Obstet. Gynecol., 193, 16, 10.1016\u002Fj.ajog.2005.03.016\nLam, 2005, Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia, Hypertension, 46, 1077, 10.1161\u002F01.HYP.0000187899.34379.b0\nKarumanchi, 2004, Hypoxia and sFlt-1 in preeclampsia: The \"Chicken-and-Egg\" question, Endocrinology, 145, 4835, 10.1210\u002Fen.2004-1028\nWallukat, 1999, Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor, J. Clin. Invest., 103, 945, 10.1172\u002FJCI4106\nDechend, 2000, AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor, Circulation, 101, 2382, 10.1161\u002F01.CIR.101.20.2382\nDechend, 2003, AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase, Circulation, 107, 1632, 10.1161\u002F01.CIR.0000058200.90059.B1\nDechend, 2005, Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia, Hypertension, 45, 742, 10.1161\u002F01.HYP.0000154785.50570.63\nDragun, 2005, Angiotensin II Type 1-receptor activating antibodies in renal-allograft rejection, N. Engl. J. Med., 352, 558, 10.1056\u002FNEJMoa035717\nBeaufils, 1981, Metabolism of uric acid in normal and pathologic pregnancy, Contrib. Nephrol., 25, 132, 10.1159\u002F000396023\nRoberts, 2001, Pathogenesis and genetics of pre-eclampsia, Lancet, 357, 53, 10.1016\u002FS0140-6736(00)03577-7\nLevine, 2004, Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia, Am. J. Obstet. Gynecol., 190, 707, 10.1016\u002Fj.ajog.2003.12.019\nRedman, 2003, Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review, Placenta, 24, S21, 10.1053\u002Fplac.2002.0930\nCockell, 1997, Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia, Hypertension, 30, 247, 10.1161\u002F01.HYP.30.2.247\nPascoal, 1998, Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries, J. Clin. Invest., 101, 464, 10.1172\u002FJCI557\nSavvidou, 2003, Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia, Lancet, 361, 1511, 10.1016\u002FS0140-6736(03)13177-7\nSugawara, 2005, Decrease and senescence of endothelial progenitor cells in patients with preeclampsia, J. Clin. Endocrinol. Metab., 90, 5329, 10.1210\u002Fjc.2005-0532\nWang, 1991, The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood, Am. J. Obstet. Gynecol., 165, 1695, 10.1016\u002F0002-9378(91)90017-L\nZemel, 1990, Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women, N. Engl. J. Med., 323, 434, 10.1056\u002FNEJM199008163230702\nBobst, 2005, Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion, Am. J. Hypertens., 18, 330, 10.1016\u002Fj.amjhyper.2004.10.002\nHirashima, 2003, Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta, Proc. Natl. Acad. Sci. USA, 100, 15637, 10.1073\u002Fpnas.2635424100\nRaijmakers, 2004, Oxidative stress and preeclampsia: rationale for antioxidant clinical trials, Hypertension, 44, 374, 10.1161\u002F01.HYP.0000141085.98320.01\nChesley, 1976, The remote prognosis of eclamptic women. Sixth periodic report, Am. J. Obstet. Gynecol., 124, 446, 10.1016\u002F0002-9378(76)90168-X\nSibai, 1986, Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis, Am. J. Obstet. Gynecol., 155, 1011, 10.1016\u002F0002-9378(86)90336-4\nSibai, 1992, Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis, Am. J. Obstet. Gynecol., 166, 1757, 10.1016\u002F0002-9378(92)91566-S\nPouta, 2004, Manifestations of metabolic syndrome after hypertensive pregnancy, Hypertension, 43, 825, 10.1161\u002F01.HYP.0000120122.39231.88\nWilson, 2003, Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study, BMJ, 326, 845, 10.1136\u002Fbmj.326.7394.845\nFisher, 1981, Hypertension in pregnancy: clinical-pathological correlations and remote prognosis, Medicine, 60, 267, 10.1097\u002F00005792-198107000-00002\nDelauche, 1980, Relevance of the renal biopsy to the future course of preeclamptic women, 219\nForest, 2005, Early Occurrence of Metabolic Syndrome After Hypertension in Pregnancy, Obstet. Gynecol., 105, 1373, 10.1097\u002F01.AOG.0000163252.02227.f8\nSmith, 2001, Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births, Lancet, 357, 2002, 10.1016\u002FS0140-6736(00)05112-6\nIrgens, 2001, Long-term mortality of mothers and fathers after pre-eclampsia: population based cohort study Pre-eclampsia and cardiovascular disease later in life: who is at risk?, BMJ, 323, 1213, 10.1136\u002Fbmj.323.7323.1213\nAgatisa, 2004, Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk, Am. J. Physiol. Heart Circ. Physiol., 286, H1389, 10.1152\u002Fajpheart.00298.2003\nSattar, 2002, Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?, BMJ, 325, 157, 10.1136\u002Fbmj.325.7356.157\nBarker, 1989, Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease, BMJ, 298, 564, 10.1136\u002Fbmj.298.6673.564\nAlexander, 2003, Placental insufficiency leads to development of hypertension in growth-restricted offspring, Hypertension, 41, 457, 10.1161\u002F01.HYP.0000053448.95913.3D\nHughson, 2003, Glomerular number and size in autopsy kidneys: the relationship to birth weight, Kidney Int., 63, 2113, 10.1046\u002Fj.1523-1755.2003.00018.x\nIngelfinger, 2004, Pathogenesis of perinatal programming, Curr. Opin. Nephrol. Hypertens., 13, 459, 10.1097\u002F01.mnh.0000133977.09688.2f",{"ES":162},"Hipertensión arterial durante el embarazo: aspectos fisiopatológicos y pronóstico a largo plazo",{"VOID":164},"10.1016\u002Fs1283-081x(06)47739-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06477390",[167,182,197],{"id":168,"sortIndex":18,"researcher":17,"roles":169,"affiliations":170,"properties":179},"854499d3-3839-4621-8155-e219710ce002",[48],[171],{"id":17,"sortIndex":18,"affiliation":172,"properties":17},{"id":173,"createTime":174,"updateTime":174,"relativeEntities":175,"slug":17,"properties":176,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"584142c5-e856-4c4f-981d-168535254e0d","2024-01-24T17:08:39.981+00:00",[],{"title":177},{"VI":178},"Service de médecine interne, Hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":180},{"VI":181},"M. Beaufils",{"id":183,"sortIndex":46,"researcher":17,"roles":184,"affiliations":185,"properties":194},"fc52890a-d43a-411f-b173-8c8087dfad47",[48],[186],{"id":17,"sortIndex":18,"affiliation":187,"properties":17},{"id":188,"createTime":189,"updateTime":189,"relativeEntities":190,"slug":17,"properties":191,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"738b15d1-5be0-4c2e-8a5a-4f8d5a5b8aa2","2024-02-06T21:03:01.686+00:00",[],{"title":192},{"VI":193},"Service de gynécologie obstétrique, Centre Hospitalier Intercommunal, 94000 Créteil, France",{"title":195},{"VI":196},"B. Haddad",{"id":198,"sortIndex":76,"researcher":17,"roles":199,"affiliations":200,"properties":209},"3c825077-a5b8-4d99-9db8-60fd105cd32b",[48],[201],{"id":17,"sortIndex":18,"affiliation":202,"properties":17},{"id":203,"createTime":204,"updateTime":204,"relativeEntities":205,"slug":17,"properties":206,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"12d9f0f8-a63e-4b8b-844d-097a67a37dd1","2024-02-06T21:03:01.699+00:00",[],{"title":207},{"VI":208},"Service de pharmacologie clinique, Hôpital Saint-Vincent-de-Paul, 75014 Paris, France",{"title":210},{"VI":211},"F. Bavoux",{"url":165,"publisher":213,"properties":221},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":214,"slug":9,"properties":215,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":218,"manageAffiliations":219,"indexDatabases":220,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":216,"title":217},{"VOID":12},{"EN":14},[],[],[],{"volume":222,"pages":224},{"VOID":223},"42",{"VOID":225},"1-14","2006-01-01",2006,{"id":229,"createTime":230,"updateTime":231,"relativeEntities":232,"slug":233,"properties":234,"entityType":39,"verifyStatus":40,"verifyTime":231,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":241,"fullTextUrl":17,"authors":242,"publicationType":87,"publisherRelationship":473,"citationCount":17,"citationInfo":17,"publishDate":487,"publishYear":488,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"acb5f1b3-8c57-4c14-a9c2-5d84e78f74b6","2023-12-25T18:08:55.433+00:00","2025-02-07T23:44:33.317+00:00",[],"Cirug%C3%ADa-laparosc%C3%B3pica",{"references":235,"title":237,"doi":239},{"VOID":236},"Marret, 1997, Complications de la cœlioscopie occasionnées par les trocarts, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 405\nHanney, 1999, Vascular injuries during laparoscopy associated with the Hasson technique, J. Am. Coll. Surg., 188, 337\nDuale, 2001, Conséquences physiopathologiques de la chirurgie cœlioscopique, Ann. Chir., 126, 508, 10.1016\u002FS0003-3944(01)00574-0\nJoris, 1995, Pneumothorax during laparoscopic fundoplication: diagnosis and treatment with positive end-expiratory pressure, Anesth. Analg., 81, 993\nHazebroek, 2002, Mechanical ventilation with positive end-expiratory pressure preserves arterial oxygenation during prolonged pneumoperitoneum, Surg. Endosc., 16, 685, 10.1007\u002Fs00464-001-8174-y\nCollins, 2001, Regional anesthesia for laparoscopy, Anesthesiol. Clin. North Am., 19, 43, 10.1016\u002FS0889-8537(05)70210-8\nApfel, 2004, A factorial trial of six interventions for the prevention of postoperative nausea and vomiting, N. Engl. J. Med., 350, 2441, 10.1056\u002FNEJMoa032196\nWhite, 2004, Prevention of postoperative nausea and vomiting-a multimodal solution to a persistent problem, N. Engl. J. Med., 350, 2511, 10.1056\u002FNEJMe048099\nOng, 2005, The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis, Anesth. Analg., 100, 757, 10.1213\u002F01.ANE.0000144428.98767.0E\nSarli, 2000, Prospective randomized trial of low-pressure pneumoperitoneum for reduction of shoulder-tip pain following laparoscopy, Br. J. Surg., 87, 1161, 10.1046\u002Fj.1365-2168.2000.01507.x\nFredman, 1994, Residual pneumoperitoneum: a cause of postoperative pain after laparoscopic cholecystectomy, Anesth. Analg., 79, 152, 10.1213\u002F00000539-199407000-00028\nGoldstein, 2000, Preventing postoperative pain by local anesthetic instillation after laparoscopic gynecologic surgery: a placebo-controlled comparison of bupivacaine and ropivacaine, Anesth. Analg., 91, 403\nLabaille, 2002, The clinical efficacy and pharmacokinetics of intraperitoneal ropivacaine for laparoscopic cholecystectomy, Anesth. Analg., 94, 100, 10.1213\u002F00000539-200201000-00019\nHamitouche, 2004, Postoperative pain relief after gynecologic surgery, J. Gynecol. Obstet. Biol. Reprod. (Paris), 33, 7, 10.1016\u002FS0368-2315(04)96306-5\nBenhamou, 2005, Maladie thromboembolique périopératoire et obstétricale. Pathologie gynécologique et obstétricale, Ann. Fr. Anesth. Reanim., 24, 911, 10.1016\u002Fj.annfar.2005.06.003\nBergqvist, 2002, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer, N. Engl. J. Med., 346, 975, 10.1056\u002FNEJMoa012385\nWood, 1998, The place of laparoscopic surgery in surgical gynaecology, Aust. N. Z. J. Obstet. Gynaecol., 38, 440, 10.1111\u002Fj.1479-828X.1998.tb03107.x\nPierre, 2000, Validation de la cœliochirurgie en gynécologie, J. Gynecol. Obstet. Biol. Reprod. (Paris), 29, 248\nGoffinet, 2004, Le Collège des gynécologues et obstétriciens français. Recommendations for clinical practice: management of extra-uterine pregnancy, Gynecol. Obstet. Fertil., 32, 180, 10.1016\u002Fj.gyobfe.2003.12.011\nBouyer, 2003, Risk factors for ectopic pregnancy: a comparative analysis based on a large case-control, population-based study in France, Am. J. Epidemiol., 157, 185, 10.1093\u002Faje\u002Fkwf190\nCanis, 2003, Grossesse extra-utérine : critères de choix du traitement médical ou du traitement chirurgical, J. Gynecol. Obstet. Biol. Reprod. (Paris), 32\nLundorff, 1991, Laparoscopic surgery in ectopic pregnancy: a randomized trial vs laparotomy, Acta Obstet. Gynecol. Scand., 70, 343, 10.3109\u002F00016349109007885\nPouly, 1991, Fertility after ectopic pregnancy. IV. Proposition for a therapeutic score and a strategy for surgical treatment for ectopic pregnancy, Contracept. Fertil. Sex., 19, 416\nDubuisson, 1985, Coelioscopic salpingectomy. A propos of 31 cases, J. Gynecol. Obstet. Biol. Reprod. (Paris), 14, 105\nPouly, 1987, Decrease in HCG level after conservative laparoscopic treatment of extra-uterine pregnancy, J. Gynecol. Obstet. Biol. Reprod. (Paris), 16, 195\nFernandez, 1998, Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility, Hum. Reprod., 13, 3239, 10.1093\u002Fhumrep\u002F13.11.3239\nPereira Dias, 1999, Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy, Lancet, 353, 724, 10.1016\u002FS0140-6736(98)02250-8\nJardon, 2006, Comment je fais… une ovariopexie après torsion d'annexe, Gynecol. Obstet. Fertil., 34, 529, 10.1016\u002Fj.gyobfe.2006.04.002\nRaiga, 1996, Salpingites aiguës non tuberculeuses, Rev. Prat., 46, 2145\nRaiga, 1996, Laparoscopic management of adnexal abscesses: consequences for fertility, Fertil. Steril., 66, 712, 10.1016\u002FS0015-0282(16)58623-3\nCanis, 2002, Laparoscopic management of adnexal masses: a gold standard?, Curr. Opin. Obstet. Gynecol., 14, 423, 10.1097\u002F00001703-200208000-00010\nValentin, 2003, Frequency and type of adnexal lesions in autopsy material from postmenopausal women: ultrasound study with histological correlation, Ultrasound Obstet. Gynecol., 22, 284, 10.1002\u002Fuog.212\nBruhat, 1991, Laparoscopic treatment of ovarian cysts. Indications, techniques, results. Apropos of 650 cases, Chirurgie, 117, 390\nCotte B, Canis M, Mage G. Place et limites de la cœlioscopie dans la prise en charge des tumeurs ovariennes : à propos de 844 cas. Neuvièmes journées parisiennes d’endoscopie de chirurgie et de gynécologie (JPECG), janvier 2006.\nYuen, 1997, A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses, Am. J. Obstet. Gynecol., 177, 109, 10.1016\u002FS0002-9378(97)70447-2\nStepp, 2004, Laparoscopy in the second trimester of pregnancy, Obstet. Gynecol. Clin. North Am., 31, 485, 10.1016\u002Fj.ogc.2004.05.002\nFarquhar, 2002, Hysterectomy rates in the United States 1990-1997, Obstet. Gynecol., 99, 229\nCosson, 2001, Vaginal, laparoscopic or abdominal hysterectomy for benign disorders immediate and early postoperative complications, Eur. J. Obstet. Gynecol. Reprod. Biol., 98, 231, 10.1016\u002FS0301-2115(01)00341-4\nDavid-Montefiore E. Enquête hystérectomie 2004 les résultats. Neuvièmes journées parisiennes d’endoscopie de chirurgie et de gynécologie (JPECG), janvier 2006.\nVessey, 1992, The epidemiology of hysterectomy: findings in a large cohort study, Br. J. Obstet. Gynaecol., 99, 402, 10.1111\u002Fj.1471-0528.1992.tb13758.x\nLepine, 1997, Hysterectomy surveillance. United States, 1980-93, MMWR CDC Surveill. Summ., 46, 1\nWattiez, 2002, The learning curve of total laparoscopic hysterectomy: comparative analysis of 1647 cases, J. Am. Assoc. Gynecol. Laparosc., 9, 339, 10.1016\u002FS1074-3804(05)60414-8\nLoft, 1991, Early post-operative mortality following hysterectomy. A Danish population based study 1997-1981, Br. J. Obstet. Gynaecol., 98, 147, 10.1111\u002Fj.1471-0528.1991.tb13360.x\nJohnson, 2005, Surgical approach to hysterectomy for benign gynaecological disease, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD003677.pub2\nJugnet, 2001, Comparing vaginal and coelioscopic total and subtotal hysterectomies: prospective multicentre study including 82 patients, Gynaecol. Endosc., 10, 315, 10.1046\u002Fj.1365-2508.2001.00472.x\nChapron, 1995, Indications et modalités de traitement chirurgical conservateur des myomes interstitiels et sous-séreux, J. Gynecol. Obstet. Biol. Reprod. (Paris), 24, 802\nDubuisson JB, Fauconnier A, Chapron C, Foulot H. Myomectomie cœlioscopique. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales - Gynécologie, 41-664, 1999 : 10p.\nDubuisson, 2004, Preventive uterine artery occlusion combined with laparoscopic myomectomy: a valid procedure to prevent bleeding, J. Gynecol. Surg., 20, 105, 10.1089\u002Fgyn.2004.20.105\nDubuisson, 1996, Laparoscopic myomectomy today. A good technique when correctly indicated, Hum. Reprod., 11, 934, 10.1093\u002Foxfordjournals.humrep.a019325\nBenhaim, 2005, Les limites de la myomectomie cœlioscopique, Gynecol. Obstet. Fertil., 33, 44, 10.1016\u002Fj.gyobfe.2004.11.005\nDubuisson, 2005, Lettre à la rédaction à propos de : Les limites de la myomectomie cœlioscopique, Gynecol. Obstet. Fertil., 33, 553, 10.1016\u002Fj.gyobfe.2005.06.005\nChandra, 1998\nLopes, 1994, La stérilisation tubaire. Enquête du Collège National des Gynécologues et Obstétriciens Français, J. Gynécol. Obstét. Gynecol. Reprod., 23, 729\nRioux, 2001, Female sterilization: an update, Curr. Opin. Obstet. Gynecol., 13, 377, 10.1097\u002F00001703-200108000-00002\nNardin, 2002, Techniques for the interruption of tubal patency for female sterilization, Cochrane Database Syst. Rev.\nNervo, 2000, Regrets après stérilisation tubaire, J. Gynecol. Obstet. Biol. Reprod. (Paris), 29, 485\nMartin, 1990, Histology of chocolate cysts, J. Gynecol. Surg., 6, 43, 10.1089\u002Fgyn.1990.6.43\nCanis, 1991, Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience, Fertil. Steril., 56, 616, 10.1016\u002FS0015-0282(16)54589-0\nPouly, 1997, Tubal sterility: fertilization in-vitro or surgery?, Contracept. Fertil. Sex., 25\n2002\nWatrelot, 2003, Evaluation. Is laparoscopy still the gold standard in infertility assessment? A comparison of fertiloscopy versus laparoscopy in infertility. Results of an international multicenter prospective trial: the ‘FLY’(Fertiloscopy-LaparoscopY) study, Hum. Reprod., 18, 834, 10.1093\u002Fhumrep\u002Fdeg180\nStrandell, 2002, Why does hydrosalpinx reduce fertility? The importance of hydrosalpinx fluid, Hum. Reprod., 17, 1141, 10.1093\u002Fhumrep\u002F17.5.1141\nDubuisson, 1995, Sterilization reversal: fertility results, Hum. Reprod., 10, 1145, 10.1093\u002Foxfordjournals.humrep.a136108\nBarjot, 1999, Laparoscopic tubal anastomosis and reversal of sterilization, Hum. Reprod., 14, 1222, 10.1093\u002Fhumrep\u002F14.5.1222\nScali, 1974, Les opérations de soutènement-suspension par voie haute dans le traitement des prolapsus vaginaux, J. Gynecol. Obstet. Biol. Reprod. (Paris), 3, 365\nDenoit, 2000, Colposuspension cœlioscopique selon Burch. Résultats avec 30 mois de recul, Ann. Chir., 125, 757, 10.1016\u002FS0003-3944(00)00272-8\nRozet, 2005, Laparoscopic sacral colpopexy approach for genito-urinary prolapse: experience with 363 cases, Eur. Urol., 47, 230, 10.1016\u002Fj.eururo.2004.08.014\nCosson, 2000, Laparoscopic sacral colpopexy: short-term results and complications in 83 patients, J. Gynecol. Obstet. Biol. Reprod. (Paris), 29, 746\nCheret, 2001, Laparoscopic promontofixation feasibility study in 44 patients, J. Gynecol. Obstet. Biol. Reprod. (Paris), 30, 139\nGadonneix, 2004, Laparoscopic sacrocolpopexy with two separate meshes along the anterior and posterior vaginal walls for multicompartment pelvic organ prolapse, J. Am. Assoc. Gynecol. Laparosc., 11, 29, 10.1016\u002FS1074-3804(05)60006-0\nParaiso, 2004, Laparoscopic Burch colposuspension versus Tension-Free Vaginal Tape: a randomized trial, Obstet. Gynecol., 104, 1249, 10.1097\u002F01.AOG.0000146290.10472.b3\nMaher, 2004, Surgical management of pelvic organ prolapse in women, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD004014.pub2\nJacquetin, 2005\nChapron C, Fauconnier A, Dubuisson JB, Fritel X. Algies pelviennes chroniques de la femme : orientation diagnostique et conduite à tenir. EMC (Elsevier Masson SAS, Paris), Gynécologie, 162-A-10, 2000 : 7p.\nHalperin, 2003, Long-term follow-up (5-20 years) after uterine ventrosuspension for chronic pelvic pain and deep dyspareunia, Gynecol. Obstet. Invest., 55, 216, 10.1159\u002F000072077\nCosson, 1996, Douleurs pelviennes et troubles de la statique pelvienne, 181\nHowards, 1993, The role of laparoscopy in chronic pelvic pain: promise and pitfalls, Obstet. Gynecol. Surv., 48, 357, 10.1097\u002F00006254-199306000-00001\nKoninckx, 1991, Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain, Fertil. Steril., 55, 759, 10.1016\u002FS0015-0282(16)54244-7\nNezhat, 1996, Long-term outcome of laparoscopic adhesiolysis in women with chronic pelvic pain after hysterectomy, J. Am. Assoc. Gynecol. Laparosc., 3\nSaravelos, 1995, An analysis of the outcome of microsurgical and laparoscopic adhesiolysis for chronic pelvic pain, Hum. Reprod., 10, 2895, 10.1093\u002Foxfordjournals.humrep.a135814\nCanis, 2001, Prevention of peritoneal adhesions, J. Gynecol. Obstet. Biol. Reprod. (Paris), 30, 305\nStones, 2000, Related Articles, links interventions for treating chronic pelvic pain in women, Cochrane Database Syst. Rev.\nCandiani, 1992, Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study, Am. J. Obstet. Gynecol., 167, 100, 10.1016\u002FS0002-9378(11)91636-6\nZullo, 2003, Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: a 1-year prospective randomized double-blind controlled trial, Am. J. Obstet. Gynecol., 189, 5, 10.1067\u002Fmob.2003.358\nCanis, 2001, Risk of spread of ovarian cancer after laparoscopic surgery, Curr. Opin. Obstet. Gynecol., 13, 9, 10.1097\u002F00001703-200102000-00002\nCanis, 2000, Cancer and laparoscopy, experimental studies: a review, Eur. J. Obstet. Gynecol. Reprod. Biol., 91, 1, 10.1016\u002FS0301-2115(99)00251-1\nSchneider, 2001, Efficacy of surgical measures in preventing port-site recurrences in a porcine model, Surg. Endosc., 15, 121, 10.1007\u002Fs004640010069\nCanis, 2003, Peritoneum and laparoscopy: the revolution is ahead!, Ann. Chir., 128, 577, 10.1016\u002Fj.anchir.2003.09.001\n2004, Related Articles, Links A comparison of laparoscopically assisted and open colectomy for colon cancer, N. Engl. J. Med., 350, 2050, 10.1056\u002FNEJMoa032651\nPomel, 2003, Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study, Gynecol. Oncol., 91, 534, 10.1016\u002Fj.ygyno.2003.08.035\nSonoda, 2003, Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach, Gynecol. Oncol., 91, 326, 10.1016\u002Fj.ygyno.2003.07.008\nCartron, 2005, Complications of laparoscopic lymphadenectomy in gynaecologic oncology. A series of 1102 procedures in 915 patients, Gynecol. Obstet. Fertil., 33, 304, 10.1016\u002Fj.gyobfe.2005.04.002\nTozzi, 2005, Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study, J. Minim. Invasive Gynecol., 12, 130, 10.1016\u002Fj.jmig.2005.01.021\nCanis, 2000, Management of adnexal masses: role and risk of laparoscopy, Semin. Surg. Oncol., 19, 28, 10.1002\u002F1098-2388(200007\u002F08)19:1\u003C28::AID-SSU5>3.0.CO;2-C\nFauvet, 2006, Faisabilité et limites du traitement cœlioscopique des tumeurs frontières de l'ovaire, Gynecol. Obstet. Fertil., 34, 470, 10.1016\u002Fj.gyobfe.2006.03.022\nKurman, 1993, The behavior of serous tumors of low malignant potential: are they ever malignant?, Int. J. Gynecol. Pathol., 12, 120, 10.1097\u002F00004347-199304000-00006\nTrimble, 2002, Long-term survival and patterns of care in women with ovarian tumors of low malignant potential, Gynecol. Oncol., 86, 34, 10.1006\u002Fgyno.2002.6711\nTozzi, 2005, Laparoscopic treatment of early ovarian cancer, Curr. Opin. Obstet. Gynecol., 17, 354, 10.1097\u002F01.gco.0000175352.95436.fc",{"ES":238},"Cirugía laparoscópica",{"VOID":240},"10.1016\u002Fs1283-081x(08)70810-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708105",[243,259,275,291,303,315,327,343,356,369,382,395,408,421,434,447,460],{"id":244,"sortIndex":245,"researcher":17,"roles":246,"affiliations":247,"properties":256},"0fb1c5dd-ea50-477b-aa73-efaea770a56b",9,[48],[248],{"id":17,"sortIndex":18,"affiliation":249,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":252,"slug":17,"properties":253,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"c3ed7c8b-cf19-409f-a0a4-772253bfb6a0","2023-12-25T18:08:55.844+00:00",[],{"title":254},{"VI":255},"Département de gynécologie-obstétrique, Polyclinique Hôtel-Dieu, CHU, 63000 Clermont-Ferrand, France",{"title":257},{"VI":258},"K. Jardon",{"id":260,"sortIndex":261,"researcher":17,"roles":262,"affiliations":263,"properties":272},"036a0d39-8a5d-4448-8f51-810652e631b1",5,[48],[264],{"id":17,"sortIndex":18,"affiliation":265,"properties":17},{"id":266,"createTime":267,"updateTime":267,"relativeEntities":268,"slug":17,"properties":269,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"b2e6546f-e3a5-4b15-bac0-ea113a637666","2023-12-21T07:09:07.445+00:00",[],{"title":270},{"VI":271},"Service de Gynécologie Obstétrique, CHU Farhat Hached, Sousse, Tunisie",{"title":273},{"VI":274},"S. Boughizane",{"id":276,"sortIndex":277,"researcher":17,"roles":278,"affiliations":279,"properties":288},"dafa9582-556e-4ed2-8647-b2da1e9a0e27",15,[48],[280],{"id":17,"sortIndex":18,"affiliation":281,"properties":17},{"id":282,"createTime":283,"updateTime":283,"relativeEntities":284,"slug":17,"properties":285,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"3ef84046-8d42-4eda-9c50-9ef0888bfa41","2023-12-25T18:08:55.822+00:00",[],{"title":286},{"VI":287},"Clinique de la Pergola, 75, allée des ailes, 03205 Vichy cedex, France",{"title":289},{"VI":290},"H. Manhès",{"id":292,"sortIndex":18,"researcher":17,"roles":293,"affiliations":294,"properties":300},"2a26e0bb-dcfe-4ae3-a817-5d9c7e593245",[48],[295],{"id":17,"sortIndex":18,"affiliation":296,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":297,"slug":17,"properties":298,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":299},{"VI":255},{"title":301},{"VI":302},"B. Cotte",{"id":304,"sortIndex":46,"researcher":17,"roles":305,"affiliations":306,"properties":312},"0d57a9bd-fe39-4e5d-adc1-c1859d3c855c",[48],[307],{"id":17,"sortIndex":18,"affiliation":308,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":309,"slug":17,"properties":310,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":311},{"VI":255},{"title":313},{"VI":314},"C. de Lapasse",{"id":316,"sortIndex":76,"researcher":17,"roles":317,"affiliations":318,"properties":324},"b7ea353d-20e1-46e7-84f9-07ec85ca4909",[48],[319],{"id":17,"sortIndex":18,"affiliation":320,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":321,"slug":17,"properties":322,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":323},{"VI":255},{"title":325},{"VI":326},"E. Nohuz",{"id":328,"sortIndex":329,"researcher":17,"roles":330,"affiliations":331,"properties":340},"bdd2db50-dcd3-4709-a5c3-196b3e14436c",7,[48],[332],{"id":17,"sortIndex":18,"affiliation":333,"properties":17},{"id":334,"createTime":335,"updateTime":335,"relativeEntities":336,"slug":17,"properties":337,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"cff45a20-5212-410a-96a6-541a02b21fac","2023-12-25T18:08:55.779+00:00",[],{"title":338},{"VI":339},"Département d'anesthésie-réanimation, Polyclinique Hôtel-Dieu, CHU, 63000 Clermont-Ferrand, France",{"title":341},{"VI":342},"M. Bonnin",{"id":344,"sortIndex":345,"researcher":17,"roles":346,"affiliations":347,"properties":353},"58067330-63ec-4b33-b7a0-c43c01ac70c7",10,[48],[348],{"id":17,"sortIndex":18,"affiliation":349,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":350,"slug":17,"properties":351,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":352},{"VI":255},{"title":354},{"VI":355},"C. Houlle",{"id":357,"sortIndex":358,"researcher":17,"roles":359,"affiliations":360,"properties":366},"31aa0136-d15d-40a6-8283-511733fe7006",12,[48],[361],{"id":17,"sortIndex":18,"affiliation":362,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":363,"slug":17,"properties":364,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":365},{"VI":255},{"title":367},{"VI":368},"M. Canis",{"id":370,"sortIndex":371,"researcher":17,"roles":372,"affiliations":373,"properties":379},"5045a574-d5c6-4417-b7bf-f628df7051a8",16,[48],[374],{"id":17,"sortIndex":18,"affiliation":375,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":376,"slug":17,"properties":377,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":378},{"VI":255},{"title":380},{"VI":381},"G. Mage",{"id":383,"sortIndex":384,"researcher":17,"roles":385,"affiliations":386,"properties":392},"d9448a5a-8907-402b-9a86-98542ba19fa0",4,[48],[387],{"id":17,"sortIndex":18,"affiliation":388,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":389,"slug":17,"properties":390,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":391},{"VI":255},{"title":393},{"VI":394},"S. Tamburro",{"id":396,"sortIndex":397,"researcher":17,"roles":398,"affiliations":399,"properties":405},"0749b20f-8377-4266-a727-0f5604161a97",14,[48],[400],{"id":17,"sortIndex":18,"affiliation":401,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":402,"slug":17,"properties":403,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":404},{"VI":255},{"title":406},{"VI":407},"A. Wattiez",{"id":409,"sortIndex":410,"researcher":17,"roles":411,"affiliations":412,"properties":418},"aafdeb14-c83a-464d-bba8-129fb0956a68",11,[48],[413],{"id":17,"sortIndex":18,"affiliation":414,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":415,"slug":17,"properties":416,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":417},{"VI":255},{"title":419},{"VI":420},"B. Rabischong",{"id":422,"sortIndex":423,"researcher":17,"roles":424,"affiliations":425,"properties":431},"9622b854-16bd-43c2-870c-6d29646b84b5",6,[48],[426],{"id":17,"sortIndex":18,"affiliation":427,"properties":17},{"id":334,"createTime":335,"updateTime":335,"relativeEntities":428,"slug":17,"properties":429,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":430},{"VI":339},{"title":432},{"VI":433},"F. Bolandard",{"id":435,"sortIndex":436,"researcher":17,"roles":437,"affiliations":438,"properties":444},"fdc1af3f-d26f-4f23-8447-9945e1f62bd7",13,[48],[439],{"id":17,"sortIndex":18,"affiliation":440,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":441,"slug":17,"properties":442,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":443},{"VI":255},{"title":445},{"VI":446},"J.-L. Pouly",{"id":448,"sortIndex":449,"researcher":17,"roles":450,"affiliations":451,"properties":457},"f0904797-eac4-4941-a65a-661738182972",3,[48],[452],{"id":17,"sortIndex":18,"affiliation":453,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":454,"slug":17,"properties":455,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":456},{"VI":255},{"title":458},{"VI":459},"C. Rivoire",{"id":461,"sortIndex":462,"researcher":17,"roles":463,"affiliations":464,"properties":470},"3d178bd5-b93a-4f85-ad00-12d25ed98016",8,[48],[465],{"id":17,"sortIndex":18,"affiliation":466,"properties":17},{"id":250,"createTime":251,"updateTime":251,"relativeEntities":467,"slug":17,"properties":468,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":469},{"VI":255},{"title":471},{"VI":472},"R. Botchorishvili",{"url":241,"publisher":474,"properties":482},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":475,"slug":9,"properties":476,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":479,"manageAffiliations":480,"indexDatabases":481,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":477,"title":478},{"VOID":12},{"EN":14},[],[],[],{"volume":483,"pages":485},{"VOID":484},"44",{"VOID":486},"1-22","2008-01-01",2008,{"id":490,"createTime":491,"updateTime":492,"relativeEntities":493,"slug":494,"properties":495,"entityType":39,"verifyStatus":40,"verifyTime":492,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":502,"fullTextUrl":17,"authors":503,"publicationType":87,"publisherRelationship":531,"citationCount":17,"citationInfo":17,"publishDate":226,"publishYear":227,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"933959fa-4cea-4fc1-8711-6e76b0648947","2023-12-09T21:30:11.723+00:00","2024-12-11T23:44:07.934+00:00",[],"S%C3%ADndrome-de-transfusi%C3%B3n-fetofetal-diagn%C3%B3stico-y-tratamiento",{"references":496,"title":498,"doi":500},{"VOID":497},"Schachter, 2001, Monozygotic twinning after assisted reproductive techniques: a phenomenon independent of micromanipulation, Hum. Reprod., 16, 1264, 10.1093\u002Fhumrep\u002F16.6.1264\nMachin, 1996, Correlations of placental vascular anatomy and clinical outcomes in 69 monochorionic twin pregnancies, Am. J. Med. Genet., 61, 229, 10.1002\u002F(SICI)1096-8628(19960122)61:3\u003C229::AID-AJMG6>3.0.CO;2-P\nSebire, 2000, Early prediction of severe twin-to-twin transfusion syndrome, Hum. Reprod., 15, 2008, 10.1093\u002Fhumrep\u002F15.9.2008\nBajoria, 1995, Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 172, 856, 10.1016\u002F0002-9378(95)90011-X\nBlickstein, 1998, Biblical twins, Obstet. Gynecol., 91, 632, 10.1016\u002FS0029-7844(98)00034-9\nDenbow, 1998, Haematological indices at fetal blood sampling in monochorionic pregnancies complicated by feto-fetal transfusion syndrome, Prenat. Diagn., 18, 941, 10.1002\u002F(SICI)1097-0223(199809)18:9\u003C941::AID-PD427>3.0.CO;2-G\nFesslova, 1998, Fetal and neonatal echocardiographic findings in twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 179, 1056, 10.1016\u002FS0002-9378(98)70215-7\nMatias, 2000, Anticipating twin-twin transfusion syndrome in monochorionic twin pregnancy. Is there a role for nuchal translucency and ductus venosus blood flow evaluation at 11-14 weeks?, Twin Res., 3, 65, 10.1375\u002F136905200320565490\nTaylor, 2000, Doppler detection of arterio-arterial anastomoses in monochorionic twins: feasability and clinical application, Hum. Reprod., 15, 1632, 10.1093\u002Fhumrep\u002F15.7.1632\nWee, 2004, Reversal of twin-twin transfusion syndrome: frequency, vascular anatomy, associated anomalies and outcome, Prenat. Diagn., 24, 104, 10.1002\u002Fpd.799\nRobyr, 2004, Permanent feto-fetal transfusion from the recipient to the donor twin. A complication of laser surgery in twin-to-twin transfusion syndrome. [abstract], Am. J. Obstet. Gynecol., 191, S163, 10.1016\u002Fj.ajog.2004.10.476\nQuintero, 1999, Staging of twin-twin transfusion syndrome, J. Perinatol., 19, 550, 10.1038\u002Fsj.jp.7200292\nTan, 2004, Doppler for artery-artery anastomosis predicts stage-independent survival in twin-twin transfusion, Obstet. Gynecol., 103, 1174, 10.1097\u002F01.AOG.0000127881.34144.d8\nVille, 1997, Monochorionic twin pregancies: « les liaisons dangereuses », Ultrasound Obstet. Gynecol., 10, 82, 10.1046\u002Fj.1469-0705.1997.10020082.x\nDe Lia, 1985, Twin transfusion syndrome: successful in utero treatment with digoxin, Int. J. Gynaecol. Obstet., 23, 197, 10.1016\u002F0020-7292(85)90104-3\nHubinont, 1996, Nd: YAG laser and needle disruption of the interfetal septum: a possible therapy in severe twin-twin transfusion syndrome, J. Gynecol. Surg., 12, 183, 10.1089\u002Fgyn.1996.12.183\nBajoria, 1998, Abundant vascular anastomoses in monoamniotic versus diamniotic monochorionic placentas, Am. J. Obstet. Gynecol., 179, 788, 10.1016\u002FS0002-9378(98)70084-5\nUmur, 2003, Monoamniotic-versus diamniotic-monochorionic twin placentas: anastomoses and twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 189, 1325, 10.1067\u002FS0002-9378(03)00811-1\nSaade, 1998, Amniotic septostomy for the treatment of twin oligohydramnios-polyhydramnios sequence, Fetal Diagn. Ther., 13, 86, 10.1159\u002F000020812\nJohnson, 2001, Amnioreduction versus septostomy in twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 185, 1044, 10.1067\u002Fmob.2001.117640\nSaade, 2002, A randomized trial of septostomy versus amnioreduction in the treatment of twin oligohydramnios polyhydramnios sequence (TOPS). [abstract], Am. J. Obstet. Gynecol., 187, S54\nHartung, 2000, Amniotic fluid pressure in both cavities of twin-to-twin transfusion syndrome: a vote against septostomy, Fetal Diagn. Ther., 15, 79, 10.1159\u002F000020980\nUmur, 2001, Fetal urine and amniotic fluid in monochorionic twins with twin-twin transfusion syndrome: simulations of therapy, Am. J. Obstet. Gynecol., 185, 996, 10.1067\u002Fmob.2001.117972\nHubinont, 2000, Twin-to-twin transfusion syndrome: treatment by amniodrainage and septostomy, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 141, 10.1016\u002FS0301-2115(00)00438-3\nMari, 2001, Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the international amnioreduction registry, Am. J. Obstet. Gynecol., 185, 708, 10.1067\u002Fmob.2001.117188\nVille, 1996, Amniotic fluid pressure in twin-to-twin transfusion syndrome: an objective prognostic factor, Fetal Diagn. Ther., 11, 176, 10.1159\u002F000264299\nSmith, 1997, Doppler evidence of improved fetoplacental hemodynamics following amnioreduction in the stuck twin phenomenon, Obstet. Gynecol., 90, 681, 10.1016\u002FS0029-7844(97)00273-1\nvan Gemert, 2001, Twin-twin transfusion syndrome: etiology, severity and rational management, Curr. Opin. Obstet. Gynecol., 13, 193, 10.1097\u002F00001703-200104000-00015\nBajoria, 1998, Chorionic plate vascular anatomy determines the efficacy of amnioreduction therapy for twin-twin transfusion syndrome, Hum. Reprod., 13, 1709, 10.1093\u002Fhumrep\u002F13.6.1709\nHuber, 2004, How can we diagnose and manage twin-twin transfusion syndrome?, Best Pract. Res. Clin. Obstet. Gynaecol., 18, 543, 10.1016\u002Fj.bpobgyn.2004.04.006\nVan Peborgh, 1997, Effect of laser coagulation on placental vessels: histological aspects, Fetal Diagn. Ther., 12, 32, 10.1159\u002F000264421\nDe Lia, 1990, Fetoscopic neodymium: YAG Laser occlusion of placental vessels in severe twin-twin transfusion syndrome, Obstet. Gynecol., 75, 1046\nVille, 1992, Successful outcome after Nd: YAG laser separation of chorioangiopagus-twins under sonoendoscopic control, Ultrasound Obstet. Gynecol., 2, 429, 10.1046\u002Fj.1469-0705.1992.02060429.x\nDe Lia, 1999, Treating previable twin-twin transfusion syndrome with laser surgery: outcomes following the learning curve, J. Perinat. Med., 27, 61, 10.1515\u002FJPM.1999.007\nJain, 2004, The twin-twin transfusion syndrome, Clin. Obstet. Gynecol., 47, 181, 10.1097\u002F00003081-200403000-00020\nVille, 1998, Endoscopic laser coagulation in the management of severe twin-to-twin transfusion syndrome, Br. J. Obstet. Gynaecol., 105, 446, 10.1111\u002Fj.1471-0528.1998.tb10132.x\nQuintero, 1998, Selective photocoagulation of placental vessels in twin-twin transfusion syndrome: evolution of a surgical technique, Obstet. Gynecol. Surv., 53\nQuintero, 2000, Selective versus non-selective laser photocoagulation of placental vessels in twin-to-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 16, 230, 10.1046\u002Fj.1469-0705.2000.00265.x\nQuintero, 2003, Stage-based treatment of twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 188, 1333, 10.1067\u002Fmob.2003.292\nHecher, 1999, Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 180, 717, 10.1016\u002FS0002-9378(99)70278-4\nHecher, 2000, Endoscopic laser coagulation of placental anastomoses in 200 pregnancies with severe mid-trimester twin-to-twin transfusion syndrome, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 135, 10.1016\u002FS0301-2115(00)00437-1\nSenat, 2004, Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome, N. Engl. J. Med., 351, 136, 10.1056\u002FNEJMoa032597\nBanek, 2003, Long-term neurodevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 188, 876, 10.1067\u002Fmob.2003.202\nFusi, 1991, Acute twin-twin transfusion: possible mechanism for brain damaged survivors after intrauterine death of a monochorionic twin, Obstet. Gynecol., 78, 523\nNicolini, 1999, Single fetal death in monochorionic twin pregnancies, Ultrasound Obstet. Gynecol., 14, 297, 10.1046\u002Fj.1469-0705.1999.14050297.x\nDommergues, 1995, Twin-to-twin transfusion syndrome: selective feticide by embolization of the hydropic fetus, Fetal Diagn. Ther., 10, 26, 10.1159\u002F000264188\nTaylor, 2002, Ultrasound-guided umbilical cord occlusion using bipolar diathermy for stage III\u002FIV twin-twin transfusion syndrome, Prenat. Diagn., 22, 70, 10.1002\u002Fpd.256\nNakata, 2004, Umbilical cord occlusion of the donor versus recipient fetus in twin-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 23, 446, 10.1002\u002Fuog.1034\nRobyr R, Yamamoto M, Ville Y. Selective feticide in complicated monochorionic twin pregnancies using ultrasound guided bipolar cord coagulation. Br. J. Obstet. Gynaecol 2005.\nSenat, 2003, The value of middle cerebral artery peak systolic velocity in the diagnosis of fetal anemia after intrauterine death of one monochorionic twin, Am. J. Obstet. Gynecol., 189, 1320, 10.1067\u002FS0002-9378(03)00644-6\nSenat, 2002, Management of single death in twin-to-twin transfusion syndrome: a role for fetal blood sampling, Ultrasound Obstet. Gynecol., 20, 360, 10.1046\u002Fj.1469-0705.2002.00815.x\nLarroche, 1990, Brain damage in monozygous twins, Biol. Neonat., 57, 261, 10.1159\u002F000243201\nQuarello E, Ville Y. Imagerie des grossesses gémellaires. Sauramps Edition, 2005.\nHuber, 2004, How can we diagnose and manage twin-twin transfusion syndrome? Best Practice & Research Clinical Obstetrics & Gynaecology, Volume 18, Issue, 4, 543\nLewi, 2003, Monochorionic diamniotic twins: complications and management options, Curr. Opin. Obstet. Gynecol., 15, 177, 10.1097\u002F00001703-200304000-00013",{"ES":499},"Síndrome de transfusión fetofetal: diagnóstico y tratamiento",{"VOID":501},"10.1016\u002Fs1283-081x(06)46496-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06464961",[504,519],{"id":505,"sortIndex":46,"researcher":17,"roles":506,"affiliations":507,"properties":516},"f58b2747-df57-48d8-8c5d-b71ad06188c9",[48],[508],{"id":17,"sortIndex":18,"affiliation":509,"properties":17},{"id":510,"createTime":511,"updateTime":511,"relativeEntities":512,"slug":17,"properties":513,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"d9806978-f0e0-486f-9622-cce63c7b9eb9","2023-12-09T21:30:11.737+00:00",[],{"title":514},{"VI":515},"Service de gynécologie-obstétrique, centre hospitalier intercommunal de Poissy, 10, rue du Champ-Gaillard, 78303 Poissy, France",{"title":517},{"VI":518},"Y. Ville",{"id":520,"sortIndex":18,"researcher":17,"roles":521,"affiliations":522,"properties":528},"0604e056-1bf9-4d91-acd2-f967a29fed49",[48],[523],{"id":17,"sortIndex":18,"affiliation":524,"properties":17},{"id":510,"createTime":511,"updateTime":511,"relativeEntities":525,"slug":17,"properties":526,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":527},{"VI":515},{"title":529},{"VI":530},"E. Quarello",{"url":502,"publisher":532,"properties":540},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":533,"slug":9,"properties":534,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":537,"manageAffiliations":538,"indexDatabases":539,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":535,"title":536},{"VOID":12},{"EN":14},[],[],[],{"volume":541,"pages":542},{"VOID":223},{"VOID":543},"1-11",{"id":545,"createTime":546,"updateTime":546,"relativeEntities":547,"slug":17,"properties":548,"entityType":39,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":555,"fullTextUrl":17,"authors":556,"publicationType":87,"publisherRelationship":608,"citationCount":17,"citationInfo":17,"publishDate":150,"publishYear":151,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"e79e628b-a5ca-434e-bd2e-d3bebf37e770","2024-02-11T23:41:12.037+00:00",[],{"references":549,"title":551,"doi":553},{"VOID":550},"Cantwell, 2011, Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom, BJOG, 118, 1\nRoyal College of Obstetricians and Gynaecologists. Antepartum haemorrhage. Green-top guidelines 2011;(n°63).\nSaucedo, 2013, Maternal mortality in France, 2007-2009, J Gynecol Obstet Biol Reprod, 42, 613, 10.1016\u002Fj.jgyn.2013.06.011\nKayem, 2014, Management of placenta previa and accreta, J Gynecol Obstet Biol Reprod, 43, 1142, 10.1016\u002Fj.jgyn.2014.10.007\nSentilhes, 2014, Postpartum hemorrhage: guidelines for clinical practice - text of the guidelines (short text), J Gynecol Obstet Biol Reprod, 43, 1170, 10.1016\u002Fj.jgyn.2014.10.009\nGoffinet, 2003, Hémorragies obstétricales du postpartum, 932\nAl Kadri, 2011, Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study, Arch Gynecol Obstet, 283, 1207, 10.1007\u002Fs00404-010-1522-1\nPatel, 2006, Drape estimation vs. visual assessment for estimating postpartum hemorrhage, Int J Gynaecol Obstet, 93, 220, 10.1016\u002Fj.ijgo.2006.02.014\nToledo, 2007, The accuracy of blood loss estimation after simulated vaginal delivery, Anesth Analg, 105, 1736, 10.1213\u002F01.ane.0000286233.48111.d8\nInVS; IdvsRdCNdEslMMC-jP. www.invs.sante.fr. 2010.\nDarlington, 2012, Effects of in vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood, Int J Burns Trauma, 2, 42\nJude, 2004, Hémostase et hypothermie, Sang Thromb Vaiss, 16, 515\nMcLintock, 2011, Obstetric hemorrhage, J Thromb Haemost, 9, 1441, 10.1111\u002Fj.1538-7836.2011.04398.x\nGoffinet, 1995, Practical use of sulprostone in the treatment of hemorrhages during delivery, J Gynecol Obstet Biol Reprod, 24, 209\nRaynal, 2011, Bakri balloon, Gynecol Obstet Fertil, 39, 438, 10.1016\u002Fj.gyobfe.2011.04.001\nBakri, 2001, Tamponade-balloon for obstetrical bleeding, Int J Gynaecol Obstet, 74, 139, 10.1016\u002FS0020-7292(01)00395-2\nVitthala, 2009, Use of Bakri balloon in post-partum haemorrhage: a series of 15 cases, Aust N Z J Obstet Gynaecol, 49, 191, 10.1111\u002Fj.1479-828X.2009.00968.x\nRoyal College of Obstetricians Gynaecologists, 2009\nLeduc, 2009, Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage, J Obstet Gynaecol Can, 31, 980, 10.1016\u002FS1701-2163(16)34329-8\nACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039–47.\nLalonde, 2006, Postpartum hemorrhage today: ICM\u002FFIGO initiative 2004-2006, Int J Gynaecol Obstet, 94, 243, 10.1016\u002Fj.ijgo.2006.04.016\nAya, 2014, Anesthetic management of severe or worsening postpartum hemorrhage, J Gynecol Obstet Biol Reprod, 43, 1030, 10.1016\u002Fj.jgyn.2014.10.001\nReccommandations pour la pratique clinique. Hémorragies du postpartum immédiat. J Gynecol Obstet Biol Reprod 2004; 33(Suppl. 8).\nBorgman, 2007, The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital, J Trauma, 63, 805, 10.1097\u002FTA.0b013e3181271ba3\nSher, 1977, Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy, Am J Obstet Gynecol, 129, 164, 10.1016\u002F0002-9378(77)90739-6\nHolcomb, 2008, Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients, Ann Surg, 248, 447, 10.1097\u002FSLA.0b013e318185a9ad\nLevy, 2014, Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy, Transfusion, 54, 1389, 10.1111\u002Ftrf.12431\nHiippala, 1995, Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates, Anesth Analg, 81, 360\nHossain, 2010, Disseminated intravascular coagulation, 394\nCharbit, 2007, The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage, J Thromb Haemost, 5, 266, 10.1111\u002Fj.1538-7836.2007.02297.x\nCortet, 2012, Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial, Br J Anaesth, 108, 984, 10.1093\u002Fbja\u002Faes096\nWikkelso, 2015, Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial, Br J Anaesth, 114, 623, 10.1093\u002Fbja\u002Faeu444\nBell, 2010, The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage, Int J Obstet Anesth, 19, 218, 10.1016\u002Fj.ijoa.2009.08.004\nWatson, 2009, Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome, J Trauma, 67, 221, 10.1097\u002FTA.0b013e3181ad5957\nDucloy-Bouthors, 2011, High-dose tranexamic acid reduces blood loss in postpartum haemorrhage, Crit Care, 15, R117, 10.1186\u002Fcc10143\nGungorduk, 2011, Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study, Am J Perinatol, 28, 233, 10.1055\u002Fs-0030-1268238\nMovafegh, 2011, Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery, Int J Gynaecol Obstet, 115, 224, 10.1016\u002Fj.ijgo.2011.07.015\nShakur, 2010, The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial, Trials, 11, 40, 10.1186\u002F1745-6215-11-40\nAhonen, 2007, An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage, Acta Anaesthesiol Scand, 51, 929, 10.1111\u002Fj.1399-6576.2007.01323.x\nAlfirevic, 2007, Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004, Obstet Gynecol, 110, 1270, 10.1097\u002F01.AOG.0000288515.48066.99\nPhillips, 2009, Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry, Anesth Analg, 109, 1908, 10.1213\u002FANE.0b013e3181c039e6\nMannucci, 2007, Prevention and treatment of major blood loss, N Engl J Med, 356, 2301, 10.1056\u002FNEJMra067742\nMcMorrow, 2008, Use of recombinant factor VIIa in massive post-partum haemorrhage, Eur J Anaesthesiol, 25, 293, 10.1017\u002FS0265021507003109\nLe Gouez, 2011, Hémorragie du postpartum, 1\nHuissoud, 2009, Coagulation assessment by rotation thrombelastometry in normal pregnancy, Thromb Haemost, 101, 755, 10.1160\u002FTH08-06-0386\nJohansson, 2009, Thrombelastography and tromboelastometry in assessing coagulopathy in trauma, Scand J Trauma, 17, 45\nOudghiri, 2011, Reference values for rotation thromboelastometry (ROTEM(R)) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters, Thromb Haemost, 106, 176, 10.1160\u002FTH11-02-0058",{"ES":552},"Hemorragias obstétricas",{"VOID":554},"10.1016\u002Fs1283-081x(20)44038-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2044038X",[557,572,584,596],{"id":558,"sortIndex":46,"researcher":17,"roles":559,"affiliations":560,"properties":569},"4274695b-f6da-4fcd-b236-44030f5a36ad",[48],[561],{"id":17,"sortIndex":18,"affiliation":562,"properties":17},{"id":563,"createTime":564,"updateTime":564,"relativeEntities":565,"slug":17,"properties":566,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"53aeca03-5a15-4fa3-9f57-d17563997a00","2024-02-11T23:41:12.073+00:00",[],{"title":567},{"VI":568},"Service d’anesthésie, CHU Louis-Mourier, AP–HP, Université Paris-7, 178, rue des Renouillers, 92701 Colombes cedex, France",{"title":570},{"VI":571},"S. Nebout",{"id":573,"sortIndex":76,"researcher":17,"roles":574,"affiliations":575,"properties":581},"2276735c-c0b1-4135-bf31-ae1b54c85d18",[48],[576],{"id":17,"sortIndex":18,"affiliation":577,"properties":17},{"id":563,"createTime":564,"updateTime":564,"relativeEntities":578,"slug":17,"properties":579,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":580},{"VI":568},{"title":582},{"VI":583},"J. Filippov",{"id":585,"sortIndex":449,"researcher":17,"roles":586,"affiliations":587,"properties":593},"709705e1-705a-40e3-a636-914bf753774a",[48],[588],{"id":17,"sortIndex":18,"affiliation":589,"properties":17},{"id":563,"createTime":564,"updateTime":564,"relativeEntities":590,"slug":17,"properties":591,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":592},{"VI":568},{"title":594},{"VI":595},"H. Keita",{"id":597,"sortIndex":18,"researcher":17,"roles":598,"affiliations":599,"properties":605},"0a5cb27e-d316-4a2b-8698-6a437678bbdf",[48],[600],{"id":17,"sortIndex":18,"affiliation":601,"properties":17},{"id":563,"createTime":564,"updateTime":564,"relativeEntities":602,"slug":17,"properties":603,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":604},{"VI":568},{"title":606},{"VI":607},"L. Ossé",{"url":555,"publisher":609,"properties":617},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":610,"slug":9,"properties":611,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":614,"manageAffiliations":615,"indexDatabases":616,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":612,"title":613},{"VOID":12},{"EN":14},[],[],[],{"volume":618,"pages":619},{"VOID":147},{"VOID":620},"1-8",{"id":622,"createTime":623,"updateTime":624,"relativeEntities":625,"slug":626,"properties":627,"entityType":39,"verifyStatus":40,"verifyTime":624,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":634,"fullTextUrl":17,"authors":635,"publicationType":87,"publisherRelationship":695,"citationCount":17,"citationInfo":17,"publishDate":709,"publishYear":710,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"ff4a9a6a-b14c-4d7d-ac42-2a3faeaefbf8","2023-12-26T12:39:34.905+00:00","2025-02-11T23:33:51.706+00:00",[],"Citogen%C3%A9tica-prenatal",{"references":628,"title":630,"doi":632},{"VOID":629},"Tijo, 1956, The chromosome number of man, Hereditas, 42, 1, 10.1111\u002Fj.1601-5223.1956.tb03010.x\nLejeune, 1959, Étude des chromosomes somatiques de neuf enfants mongoliens, CR Acad Sci Paris, 248, 1721\nBoue, 1976, Diagnostic prénatal des anomalies chromosomiques, Arch Fr Pediatr, 33, 653\nBoue, 1979, Diagnostic prénatal : résultat de 1532 ponctions amniotiques et étude prospective de 1023 cas, Nouv Presse Med, 8, 2949\nBoue, 1984, A collaborative study of the segregation of inherited chromosome structural rearrangements in 1356 prenatal diagnoses, Prenat Diagn, 4, 45, 10.1002\u002Fpd.1970040705\nGoossens, 1981, Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic fluid cells. A preliminary study in the French West-Indies, Nouv Presse Med, 10, 387\nGoossens, 1983, Prenatal diagnosis of sickle-cell anemia in the first trimester of pregnancy, N Engl J Med, 309, 831, 10.1056\u002FNEJM198310063091405\nDaffos, 1983, Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases, Prenat Diagn, 3, 271, 10.1002\u002Fpd.1970030402\nBoué, 1973, Outcome of pregnancies following a spontaneous abortion with chromosomal anomalies, Am J Obstet Gynecol, 161, 806, 10.1016\u002F0002-9378(73)91013-2\nPlachot, 1989, Chromosome analysis of spontaneous abortions after IVF. A european survey, Hum Reprod, 4, 425, 10.1093\u002Foxfordjournals.humrep.a136921\nTurleau, 2004, Types, fréquences et mécanismes de formation des anomalies chromosomiques, 71\nEdwards, 1960, A new trisomic syndrome, Lancet, 1, 787, 10.1016\u002FS0140-6736(60)90675-9\nPatau, 1960, Multiple congenital anomaly caused by an extra autosome, Lancet, 1, 790, 10.1016\u002FS0140-6736(60)90676-0\nPellestor, 1991, Frequency and distribution of aneuploidy in human female gametes, Hum Genet, 86, 283, 10.1007\u002FBF00202410\nHassold, 1993, Trisomy in human: incidence, origin and etiology, Curr Opin Genet Dev, 3, 398, 10.1016\u002F0959-437X(93)90111-2\nAngell, 1994, First meiotic division abnormalities in human aneuploidy in human ovocytes: mechanism of trisomy formation, Cytogenet Cell Genet, 65, 10.1159\u002F000133631\nDe Grouchy, 1984\nSiffroi, 1997, Assisted reproductive technology and complex chromosomal rearrangements: the limits of ICSI, Mol Hum Reprod, 3, 847, 10.1093\u002Fmolehr\u002F3.10.847\nDe la Chapelle, 1981, A deletion in chromosome 22 can cause DiGeorge syndrome, Hum Genet, 57, 253, 10.1007\u002FBF00278938\nShaffer LG, McGowan-Jordan J, Schmid M. In: ISCN: An International System for Human Cytogenetic Nomenclature (2013) Recommendations of the International Standing Committee on Human. Published in collaboration with Cytogenetic and Genome Research; 2013.\nCacheux, 1994, Evaluation of X, Y, 18, and 13\u002F21 alpha satellite DNA probes for interphase cytogenetic analysis of uncultured amniocytes by fluorescence in situ hybridization, Prenat Diagn, 14, 79, 10.1002\u002Fpd.1970140202\nShaffer, 2011, The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes, Prenat Diagn, 31, 778, 10.1002\u002Fpd.2766\nVialard, 2012, Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories, Prenat Diagn, 32, 329, 10.1002\u002Fpd.2934\nDunbar, 2006, Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection, Clin Chim Acta, 363, 71, 10.1016\u002Fj.cccn.2005.06.023\nGrati, 2013, Application of a new molecular technique for the genetic evaluation of products of conception, Prenat Diagn, 33, 32, 10.1002\u002Fpd.4004\nKeren, 2008, Nouveaux outils diagnostiques du retard mental, Mt Pediatr, 11, 230\nMalan, 2012, Diagnosis of chromosomal abnormalities by array CGH in constitutional pathology: the end of the first-line karyotype. Diagnostic des anomalies chromosomiques par CGH array en pathologie constitutionnelle : la fin du caryotype en première intention, Arch Pediatr, 19, 437, 10.1016\u002Fj.arcped.2012.01.004\nCooper, 2011, A copy number variation morbidity map of developmental delay, Nat Genet, 43, 838, 10.1038\u002Fng.909\nConrad, 2010, Origins and functional impact of copy number variation in the human genome, Nature, 464, 704, 10.1038\u002Fnature08516\nBreman, 2012, Prenatal chromosomal microarray analysis in a diagnostic laboratory: experience with >1000 cases and review of the literature, Prenat Diagn, 32, 351, 10.1002\u002Fpd.3861\nShaffer, 2012, Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies, Prenat Diagn, 32, 976, 10.1002\u002Fpd.3945\nWapner, 2012, Chromosomal microarray versus karyotyping for prenatal diagnosis, N Engl J Med, 367, 2175, 10.1056\u002FNEJMoa1203382\nLo, 2007, Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection, Nat Med, 13, 218, 10.1038\u002Fnm1530\nLo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016\u002FS0140-6736(97)02174-0\nHill, 2011, Non-invasive prenatal determination of fetal sex: translating research into clinical practice, Clin Genet, 80, 68, 10.1111\u002Fj.1399-0004.2010.01533.x\nLo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N Engl J Med, 339, 1734, 10.1056\u002FNEJM199812103392402\nTong, 2006, Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations, Clin Chem, 52, 2194, 10.1373\u002Fclinchem.2006.076851\nPalomaki, 2011, DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study, Genet Med, 13, 913, 10.1097\u002FGIM.0b013e3182368a0e\nPalomaki, 2012, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study, Genet Med, 14, 296, 10.1038\u002Fgim.2011.73\nChen, 2011, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing, Plos One, 6, e21791, 10.1371\u002Fjournal.pone.0021791\nLun, 2011, Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA, Clin Chem, 57, 917, 10.1373\u002Fclinchem.2011.161844\nCanick, 2012, DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations, Prenat Diagn, 32, 730, 10.1002\u002Fpd.3892",{"ES":631},"Citogenética prenatal",{"VOID":633},"10.1016\u002Fs1283-081x(14)67342-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14673422",[636,651],{"id":637,"sortIndex":46,"researcher":17,"roles":638,"affiliations":639,"properties":648},"72d3c4d0-1f40-4e0f-8e7e-26988da96b19",[48],[640],{"id":17,"sortIndex":18,"affiliation":641,"properties":17},{"id":642,"createTime":643,"updateTime":643,"relativeEntities":644,"slug":17,"properties":645,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"c47e9bfa-c40b-4ac0-ba77-9991db45ea9b","2023-12-26T12:39:34.932+00:00",[],{"title":646},{"VI":647},"UF de cytogénétique, Département de génétique, Hôpital Robert-Debré, AP–HP, 48, boulevard Serrurier, 75019 Paris, France",{"title":649},{"VI":650},"C. Dupont",{"id":652,"sortIndex":18,"researcher":17,"roles":653,"affiliations":654,"properties":692},"d1845436-f79a-49e4-b89d-01d9b6f27cbe",[48],[655,665,677,684],{"id":656,"sortIndex":76,"affiliation":657,"properties":664},"930769cf-358c-4e03-8af3-043c7a4c3351",{"id":658,"createTime":659,"updateTime":659,"relativeEntities":660,"slug":17,"properties":661,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"3f15a7b9-0d76-46e7-9fc4-9b02aa030d1f","2023-12-05T13:26:11.538+00:00",[],{"title":662},{"VI":663},"Université Paris 13, Sorbonne Paris Cité, Paris, France",{},{"id":666,"sortIndex":449,"affiliation":667,"properties":676},"5f36c9fb-1802-4a53-a3dd-b643b2135eb7",{"id":668,"createTime":669,"updateTime":670,"relativeEntities":671,"slug":672,"properties":673,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"5be77e49-a6ba-46ed-89a0-2a4c392ff23c","2023-12-12T09:56:22.898+00:00","2024-12-28T10:57:46.391+00:00",[],"Inserm-U676-Paris-France",{"title":674},{"VI":675},"Inserm, U676, Paris, France",{},{"id":678,"sortIndex":46,"affiliation":679,"properties":683},"22657874-6c1c-4f4a-9eab-fec9ce298889",{"id":642,"createTime":643,"updateTime":643,"relativeEntities":680,"slug":17,"properties":681,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":682},{"VI":647},{},{"id":17,"sortIndex":18,"affiliation":685,"properties":17},{"id":686,"createTime":687,"updateTime":687,"relativeEntities":688,"slug":17,"properties":689,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"d849df4b-4307-4a3d-ac24-064a86c810d2","2023-12-26T12:39:34.926+00:00",[],{"title":690},{"VI":691},"Service d’histologie-embryologie-cytogénétique-biologie de la reproduction-CECOS, Hôpital Jean-Verdier, AP–HP, avenue-du-14-Juillet, 93143 Bondy cedex, France",{"title":693},{"VI":694},"B. Benzacken",{"url":634,"publisher":696,"properties":704},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":697,"slug":9,"properties":698,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":701,"manageAffiliations":702,"indexDatabases":703,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":699,"title":700},{"VOID":12},{"EN":14},[],[],[],{"volume":705,"pages":707},{"VOID":706},"50",{"VOID":708},"1-18","2014-06-01",2014,{"id":712,"createTime":713,"updateTime":713,"relativeEntities":714,"slug":17,"properties":715,"entityType":39,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":722,"fullTextUrl":17,"authors":723,"publicationType":87,"publisherRelationship":934,"citationCount":17,"citationInfo":17,"publishDate":948,"publishYear":949,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"5f0225f9-7ccf-4de6-be59-eda5b347064a","2023-12-29T23:27:57.098+00:00",[],{"references":716,"title":718,"doi":720},{"VOID":717},"Palmer, 1948, La cœlioscopie, Bruxelles Med, 28, 305\nBruhat, 1979, Essai d’un traitement per cœlioscopique de la grossesse extra-utérine : à propos de 26 observations, Rev Fr Gynecol Obstet, 72, 667\nReich, 1989, Laparoscopic hysterectomy, J Gynecol Surg, 5, 213, 10.1089\u002Fgyn.1989.5.213\nBruhat, 1991\nHolzer, 2006, Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain, Anesth Analg, 102, 1480, 10.1213\u002F01.ane.0000204321.85599.0d\nGarry, 2006, Laparoscopic surgery, Best Pract Res Clin Obstet Gynecol, 20, 89, 10.1016\u002Fj.bpobgyn.2005.10.003\nGarry, 1997, Complications of laparoscopic entry, Gynecol Endosc, 6, 319, 10.1111\u002Fj.1365-2508.1997.151-gy0558.x\nQuerleu, 1993, Complications of gynaecological laparoscopic surgery: a French collaborative study, Gynecol Endosc, 2, 3\nChapron, 1998, Surgical complications of diagnostic and operative gynaecological laparoscopy. A series of 29 966 cases, Hum Reprod, 13, 867, 10.1093\u002Fhumrep\u002F13.4.867\nRomanowski, 1993, Brachial plexus neuropathies after advanced laparoscopic surgery, Fertil Steril, 60, 729, 10.1016\u002FS0015-0282(16)56233-5\nShveiky, 2010, Brachial plexus injury after laparoscopic and robotic surgery, J Minim Invasive Gynecol, 17, 414, 10.1016\u002Fj.jmig.2010.02.010\nEteuati, 2013, Brachial plexopathy in laparoscopic-assisted rectal surgery: a case series, Tech Coloproctol, 17, 293, 10.1007\u002Fs10151-012-0920-8\nAgostini, 2010, Patient positioning in laparoscopic surgery: tricks and tips, J Visc Surg, 147, e227, 10.1016\u002Fj.jviscsurg.2010.07.010\nMenes, 2000, Laparoscopy: searching for the proper insufflation gas, Surg Endosc, 14, 1050, 10.1007\u002Fs004640000216\nGutt, 2004, Circulatory and respiratory complications of carbon dioxide insufflations, Dig Surg, 21, 95, 10.1159\u002F000077038\nElkelani, 2004, Effect of adding more than 3% oxygen to carbon dioxide pneumoperitoneum on adhesion formation in a laparoscopic mouse model, Fertil Steril, 82, 1616, 10.1016\u002Fj.fertnstert.2004.07.933\nLarsen, 2004, Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy, Br J Surg, 91, 848, 10.1002\u002Fbjs.4573\nAlijani, 2004, Abdominal wall lift versus positive-pressure capnoperitoneum for laparoscopic cholecystectomy: randomized controlled trial, Ann Surg, 239, 388, 10.1097\u002F01.sla.0000114226.31773.e3\nNeudecker, 2002, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, Surg Endosc, 16, 1121, 10.1007\u002Fs00464-001-9166-7\nMalik, 2000, Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid, Surg Endosc, 14, 452, 10.1007\u002Fs004640000160\nLöning, 2004, Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX, Cancer, 100, 1650, 10.1002\u002Fcncr.20155\nBuchweitz, 2006, Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy, Am J Obstet Gynecol, 195, 949, 10.1016\u002Fj.ajog.2006.02.044\nBarranger, 2016, 3D laparoscopy: an intermediate technology between conventional laparoscopy and robotic surgery contributing to controlling health expenditure, Gynecol Obstet Fertil, 44, 133, 10.1016\u002Fj.gyobfe.2015.11.006\nMartern, 2005, Monitor position in laparoscopic surgery, Surg Endosc, 19, 436, 10.1007\u002Fs00464-004-9030-7\nHaveran, 2007, Optimizing laparoscopic task efficiency: the role of camera and monitor positions, Surg Endosc, 21, 980, 10.1007\u002Fs00464-007-9360-3\nKadar, 1993, Incisional hernias after major laparoscopic gynecologic procedures, Am J Obstet Gynecol, 168, 1493, 10.1016\u002FS0002-9378(11)90787-X\nSinghvi, 2002, Assessment of the physical properties of endoscopic retrieval systems, Br J Surg, 89, 1183, 10.1046\u002Fj.1365-2168.2002.02192.x\nKöchli, 2000, Endobag extractor to remove masses during laparoscopy, Obstet Gynecol, 95, 304\nRabischong, 2013, Long-term complication of laparoscopic uterine morcellation: iatrogenic parasitic myomas, J Gynecol Obstet Biol Reprod, 42, 577, 10.1016\u002Fj.jgyn.2013.07.006\nHarold, 2003, Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries, Surg Endosc, 17, 1228, 10.1007\u002Fs00464-002-8833-7\nDiamantis, 2006, Comparison of monopolar electrocoagulation, bipolar electrocoagulation, ultracision, and ligasure, Surg Today, 36, 908, 10.1007\u002Fs00595-006-3254-1\nEmam, 2003, How safe is high-power ultrasonic dissection?, Ann Surg, 237, 186, 10.1097\u002F01.SLA.0000048454.11276.62\nHensman, 1998, Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment: an in-vitro study, Surg Endosc, 12, 1017, 10.1007\u002Fs004649900771",{"ES":719},"Laparoscopia y cirugía laparoscópica: principios generales e instrumental",{"VOID":721},"10.1016\u002Fs1283-081x(18)89352-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893523",[724,749,768,787,805,824,842,860,878,897,915],{"id":725,"sortIndex":449,"researcher":17,"roles":726,"affiliations":727,"properties":746},"5b51150b-1fcc-4f40-aad2-9c7d6d2195c3",[48],[728,738],{"id":729,"sortIndex":46,"affiliation":730,"properties":737},"b7757eee-75a8-416b-affd-53b228e03161",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":733,"slug":17,"properties":734,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"51c7dc33-b902-4469-8281-e2575ec5e039","2023-12-29T23:27:57.195+00:00",[],{"title":735},{"VI":736},"Centre international de chirurgie endoscopique (CICE), Faculté de médecine, bâtiment 3C, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France",{},{"id":17,"sortIndex":18,"affiliation":739,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":742,"slug":17,"properties":743,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"5bb93a90-9a54-4256-a939-27a318b724a2","2024-01-27T02:16:05.849+00:00",[],{"title":744},{"VI":745},"Service de gynécologie obstétrique et reproduction humaine, CHU de Clermont-Ferrand, CHU Estaing, gynécologie A, 1, place Lucie-Aubrac, 63100 Clermont-Ferrand, France",{"title":747},{"VI":748},"A.-S. Gremeau",{"id":750,"sortIndex":329,"researcher":17,"roles":751,"affiliations":752,"properties":765},"cf3cbd20-1dab-4990-b7a5-9e65d9c6e532",[48],[753,760],{"id":754,"sortIndex":46,"affiliation":755,"properties":759},"4f90fcbf-a5af-4275-902e-46acd32474e6",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":756,"slug":17,"properties":757,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":758},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":761,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":762,"slug":17,"properties":763,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":764},{"VI":745},{"title":766},{"VI":767},"S. Campagne-Loiseau",{"id":769,"sortIndex":384,"researcher":17,"roles":770,"affiliations":771,"properties":784},"4dc497a9-8ecf-495e-b0ce-28954a84b752",[48],[772,777],{"id":17,"sortIndex":18,"affiliation":773,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":774,"slug":17,"properties":775,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":776},{"VI":745},{"id":778,"sortIndex":46,"affiliation":779,"properties":783},"e97337d3-faa8-4beb-bb72-9dd53ee8669f",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":780,"slug":17,"properties":781,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":782},{"VI":736},{},{"title":785},{"VI":786},"N. Bourdel",{"id":788,"sortIndex":345,"researcher":17,"roles":789,"affiliations":790,"properties":803},"d177f8c1-5702-49fd-b8a0-c8dcef470beb",[48],[791,798],{"id":792,"sortIndex":46,"affiliation":793,"properties":797},"18d6dfd5-ec1a-4fe5-857f-d1a7d7af7cd5",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":794,"slug":17,"properties":795,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":796},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":799,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":800,"slug":17,"properties":801,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":802},{"VI":745},{"title":804},{"VI":472},{"id":806,"sortIndex":18,"researcher":17,"roles":807,"affiliations":808,"properties":821},"426b44a2-0a17-4486-b249-dc457b7833a1",[48],[809,816],{"id":810,"sortIndex":46,"affiliation":811,"properties":815},"a9d43de8-a004-4a83-a375-daa4770c4630",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":812,"slug":17,"properties":813,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":814},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":817,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":818,"slug":17,"properties":819,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":820},{"VI":745},{"title":822},{"VI":823},"P. Chauvet",{"id":825,"sortIndex":46,"researcher":17,"roles":826,"affiliations":827,"properties":840},"7ee2d44b-0982-48b3-a8bd-d3380303d706",[48],[828,835],{"id":829,"sortIndex":46,"affiliation":830,"properties":834},"b40d15bc-2b8e-4de3-bf8b-cb10c8365a88",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":831,"slug":17,"properties":832,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":833},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":836,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":837,"slug":17,"properties":838,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":839},{"VI":745},{"title":841},{"VI":420},{"id":843,"sortIndex":423,"researcher":17,"roles":844,"affiliations":845,"properties":858},"8ea8a144-a2d1-4fc6-a034-545d357bf7f2",[48],[846,853],{"id":847,"sortIndex":46,"affiliation":848,"properties":852},"81fabadd-3ef5-48fe-aea4-f31a4d7d094f",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":849,"slug":17,"properties":850,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":851},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":854,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":855,"slug":17,"properties":856,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":857},{"VI":745},{"title":859},{"VI":355},{"id":861,"sortIndex":462,"researcher":17,"roles":862,"affiliations":863,"properties":876},"4abaa0da-1e3f-4cb8-9d68-80333ed2d949",[48],[864,871],{"id":865,"sortIndex":46,"affiliation":866,"properties":870},"23642951-7dae-4854-a5fc-057123c2f567",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":867,"slug":17,"properties":868,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":869},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":872,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":873,"slug":17,"properties":874,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":875},{"VI":745},{"title":877},{"VI":446},{"id":879,"sortIndex":76,"researcher":17,"roles":880,"affiliations":881,"properties":894},"6c5c1780-bf89-485b-be5b-1276bf0fbf90",[48],[882,889],{"id":883,"sortIndex":46,"affiliation":884,"properties":888},"5302a086-db83-4dda-97a8-c0c4302b3577",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":885,"slug":17,"properties":886,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":887},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":890,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":891,"slug":17,"properties":892,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":893},{"VI":745},{"title":895},{"VI":896},"S. Curinier",{"id":898,"sortIndex":245,"researcher":17,"roles":899,"affiliations":900,"properties":913},"50a35d75-166a-457e-aa0f-bc51dc21e5de",[48],[901,908],{"id":902,"sortIndex":46,"affiliation":903,"properties":907},"a82c6eb0-30f8-469a-8d98-eb19c1be368a",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":904,"slug":17,"properties":905,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":906},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":909,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":910,"slug":17,"properties":911,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":912},{"VI":745},{"title":914},{"VI":368},{"id":916,"sortIndex":261,"researcher":17,"roles":917,"affiliations":918,"properties":931},"7abcc593-9406-4a8e-b933-d84ab5352a15",[48],[919,926],{"id":920,"sortIndex":46,"affiliation":921,"properties":925},"908396d1-2c1e-464c-8489-eb97a4633d27",{"id":731,"createTime":732,"updateTime":732,"relativeEntities":922,"slug":17,"properties":923,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":924},{"VI":736},{},{"id":17,"sortIndex":18,"affiliation":927,"properties":17},{"id":740,"createTime":741,"updateTime":741,"relativeEntities":928,"slug":17,"properties":929,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":930},{"VI":745},{"title":932},{"VI":933},"A.-G. Kaemmerlen",{"url":722,"publisher":935,"properties":943},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":936,"slug":9,"properties":937,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":940,"manageAffiliations":941,"indexDatabases":942,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":938,"title":939},{"VOID":12},{"EN":14},[],[],[],{"volume":944,"pages":946},{"VOID":945},"54",{"VOID":947},"1-17","2018-06-01",2018,{"id":951,"createTime":952,"updateTime":953,"relativeEntities":954,"slug":955,"properties":956,"entityType":39,"verifyStatus":40,"verifyTime":953,"verifyNote":41,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":46,"primaryUrl":963,"fullTextUrl":17,"authors":964,"publicationType":87,"publisherRelationship":992,"citationCount":17,"citationInfo":17,"publishDate":1006,"publishYear":1007,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"e1486789-259f-443c-8672-148f897da6a9","2024-01-14T01:09:56.425+00:00","2024-12-10T23:22:55.429+00:00",[],"T%C3%A9cnicas-de-esterilizaci%C3%B3n-femenina-",{"references":957,"title":959,"doi":961},{"VOID":958},"Madlener, 1919, Über sterilisierende Operationen an den Tuben, Zentrbl. Gynäkol., 43, 380\nIrving, 1924, A new method of insuring sterility following cesaeraen section, Am. J. Obstet. Gynecol., 8, 335, 10.1016\u002FS0002-9378(24)90673-9\nGarb, 1957, A review of tubal sterilization failures, Obstet. Gynecol. Surv., 12, 291, 10.1097\u002F00006254-195706000-00001\nBishop, 1930, A simple method of tubal sterilization, NY. St. J. Med., 30, 214\nUchida, 1975, Uchida tubal sterilization, Am. J. Obstet. Gynecol., 121, 153, 10.1016\u002F0002-9378(75)90630-4\nWortman, 1976, Tubal sterilization-review of methods, Popul. Rep. C, 7, 73\nPeterson, 1996, The risk of pregnancy afetr tubal sterilization: findings from the US Collaborative review of Sterilization, Am. J. Obstet. Gynecol., 174, 1161, 10.1016\u002FS0002-9378(96)70658-0\nPeterson, 1981, Deaths associated with laparoscopic sterilization by unipolar electrocoagulating devices 1978-1979, Am. J. Obstet. Gynecol., 139, 141, 10.1016\u002F0002-9378(81)90435-X\nKroener, 1969, Surgical sterilization by fimbriectomy, Am. J. Obstet. Gynecol., 104, 247, 10.1016\u002F0002-9378(69)90671-1\nPeterson, 1999, Pregnancy after tubal sterilization with bipolar electrocoagulation. U.S. Collaborative Review of sterilization Working Group, Obstet. Gynecol., 94, 163\nSemm, 1976, Thermocoagulation by endocoagulator. A new method for pelviscopic sterilization, Gynecologie, 27, 279\nHulka, 1982, Reversibility of clip sterilizations, Lancet, 2, 927, 10.1016\u002FS0140-6736(82)90886-8\n1996, Sterilization, Int. J. Gynaecol. Obstet., 53, 281, 10.1016\u002FS0020-7292(96)90015-6\nHulka, 1979, Laparoscopic sterilization with the spring clip: instrumentation deveopment and current clinical experience, Am. J. Obstet. Gynecol., 135, 1016, 10.1016\u002F0002-9378(79)90728-2\nHulka, 1976, Spring clip sterilization: one-year follow-up of 1,079 cases, Am. J. Obstet. Gynecol., 125, 1039, 10.1016\u002F0002-9378(76)90805-X\nNewton, 1990, Female sterilization: a review of methods, morbidity, failure rates and medicolegal aspects, Contemp. Rev. Obstet. Gynecol., 2, 176\nChi, 1991, Timing of postpartum tubal sterilization using the Filshie clips: an analysis of data from two developing-country centers, Contraception, 43, 33, 10.1016\u002F0010-7824(91)90124-X\nYoon, 1974, A preliminary report on a new laparoscopic sterilization approach: the silicone rubber band technique, Am. J. Obstet. Gynecol., 120, 132, 10.1016\u002F0002-9378(74)90191-4\nDonnadieu, 2007, Essure® sterilization associated with endometrial ablation, Int. J. Gynaecol. Obstet., 97, 139, 10.1016\u002Fj.ijgo.2007.02.009\nUbeda, 2004, Essure®: a new device for hysteroscopic tubal sterilization in an out patient setting, Fertil. Steril., 82, 196, 10.1016\u002Fj.fertnstert.2003.12.032\nHeredia, 2004, Radiological control of Essure® placement, Gynecol. Surg., 1, 201, 10.1007\u002Fs10397-004-0038-8\nMascaro, 2008, Feasability of Essure® placement in intrauterine device users, J. Minim. Invasiv. Gynecol., 15, 485, 10.1016\u002Fj.jmig.2008.04.020\nShavell, 2008, Post-Essure® hysterosalpingography compliance in a clinic population, J. Minim. Invasiv. Gynecol., 15, 431, 10.1016\u002Fj.jmig.2008.03.004\nAldridge, 1934, Temporary surgical sterilization with subsequent pregnancy, Am. J. Obstet. Gynecol., 27, 741, 10.1016\u002FS0002-9378(34)90692-X\nOverstreet, 1969, Techniques of sterilization, Clin. Obstet. Gynecol., 104, 247\nNardin, 2003, Techniques for the interruption of tubal patency for female sterilisation, Cochrane Database Syst. Rev., CD003034\nSitompul, 1984, Comparison of three types of tubal sterilisation: the medan experience, Contraception, 29, 55, 10.1016\u002F0010-7824(84)90058-1\nKulier, 2004, Minilaparotomy and endoscopic techniques for tubal sterilisation, Cochrane Database Syst. Rev., CD001328\nJamieson, 2000, Complications of interval laparoscopic tubal sterilization: findings from United States collaborative review of sterilization, Obstet. Gynecol., 96, 997\nKerin, 2003, Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study, Hum. Reprod., 18, 1223, 10.1093\u002Fhumrep\u002Fdeg256\nCooper, 2003, Micro-insert nonincisional hysteroscopic sterilization, Obstet. Gynecol., 102, 59\nKerin, 2001, The safety and effectiveness of a new hysteroscopic method for permanent birth control: result of the first Essure® pbc clinical study, Aust. NZ. Obstet. Gynecol., 41, 364, 10.1111\u002Fj.1479-828X.2001.tb01311.x\nTiras, 2001, Comparison of microlaparoscopy and conventional laparoscopy for tubzl sterilization under local anesthesia with mild sedation, J. Am. Assoc. Gynecol. Laparosc., 8, 385, 10.1016\u002FS1074-3804(05)60335-0\nFrancks, 1987, Unintended laparotomy associated with laparoscopic tubal sterilization, Am. J. Obstet. Gynecol., 157, 1102, 10.1016\u002FS0002-9378(87)80269-7\n1982, Minilaparotomy or laparoscopy for sterilization, Am. J. Obstet. Gynecol., 143, 645, 10.1016\u002F0002-9378(82)90109-0\nPelland, 1976, The application of lidocaine to the fallopian tubes during tubal fulguration by laparoscopy, Obstet. Gynecol., 47, 501\nBenhamou, 1994, Postoperative pain after local anesthetics for laparoscopic sterilization, Obstet. Gynecol., 84, 877\nBaram, 1990, Intraoperative topical etidocaine for reducing postoperative pain after laparoscopic tubal ligation, J. Reprod. Med., 35, 407\nEzeh, 1995, Local anaesthetic on Filshie clips for pain relief after tubal sterilisation: a randomised double-blind controlled trial, Lancet, 346, 82, 10.1016\u002FS0140-6736(95)92112-5\nThompson, 1987, Infiltration of the mesosalpinx for pain relief after laparoscopic tubal sterilization with Yoon rings, J. Reprod. Med., 32, 537\nPeterson, 1997, The risk of ectopic pregnancy after tubal sterilization. US. Collaborative Review of sterolization Working Group, N. Engl. J. Med., 336, 762, 10.1056\u002FNEJM199703133361104\nLevy, 2007, A summary of reported pregnancies after hysteroscopic sterilization, J. Minim. Invasiv. Gynecol., 14, 271, 10.1016\u002Fj.jmig.2006.11.007\nStovall, 1991, Method failures of laparoscopic tubal sterilization in a residency training program. A comparison of the tubal ring and spring-loaded clip, J. Reprod. Med., 36, 283\nAranda, 1985, A comparative clinical trial of the tubal ring versus the Rocket clip for female sterilization, Am. J. Obstet. Gynecol., 153, 755, 10.1016\u002F0002-9378(85)90340-0\nArgueta, 1980, Comparison of laparoscopic sterilization via spring-loaded clip and tubal ring, Int. J. Gynaecol. Obstet., 18, 115, 10.1002\u002Fj.1879-3479.1980.tb00259.x\nHillis, 1999, Poststerilization regret: findings from the United States Collaborative Review of Sterilization, Obstet. Gynecol., 93, 889",{"ES":960},"Técnicas de esterilización femenina.",{"VOID":962},"10.1016\u002Fs1283-081x(10)70768-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X10707682",[965,980],{"id":966,"sortIndex":46,"researcher":17,"roles":967,"affiliations":968,"properties":977},"f01e3ea2-7358-4ef5-9430-a57732cc4942",[48],[969],{"id":17,"sortIndex":18,"affiliation":970,"properties":17},{"id":971,"createTime":972,"updateTime":972,"relativeEntities":973,"slug":17,"properties":974,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},"36015074-fc07-49a8-8080-bf56defe313e","2024-01-14T01:09:56.446+00:00",[],{"title":975},{"VI":976},"Service de gynécologie-obstétrique et médecine de la reproduction, Hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France",{"title":978},{"VI":979},"H. Fernandez",{"id":981,"sortIndex":18,"researcher":17,"roles":982,"affiliations":983,"properties":989},"e1417667-c1a8-4bc1-8091-6d65f868380b",[48],[984],{"id":17,"sortIndex":18,"affiliation":985,"properties":17},{"id":971,"createTime":972,"updateTime":972,"relativeEntities":986,"slug":17,"properties":987,"entityType":58,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18},[],{"title":988},{"VI":976},{"title":990},{"VI":991},"A. Gervaise",{"url":963,"publisher":993,"properties":1001},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":994,"slug":9,"properties":995,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":998,"manageAffiliations":999,"indexDatabases":1000,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":996,"title":997},{"VOID":12},{"EN":14},[],[],[],{"volume":1002,"pages":1004},{"VOID":1003},"46",{"VOID":1005},"1-10","2010-01-01",2010,{"id":1009,"createTime":1010,"updateTime":1011,"relativeEntities":1012,"slug":1013,"properties":1014,"entityType":39,"verifyStatus":16,"verifyTime":1011,"verifyNote":1021,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"primaryUrl":1022,"fullTextUrl":17,"authors":1023,"publicationType":87,"publisherRelationship":1031,"citationCount":17,"citationInfo":17,"publishDate":1044,"publishYear":1045,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":104},"5d147e23-856f-4e1d-8bd1-c874c357ae53","2024-01-08T13:09:17.404+00:00","2024-12-19T23:18:46.193+00:00",[],"Analgesia-y-anestesia-en-el-parto",{"references":1015,"title":1017,"doi":1019},{"VOID":1016},"Abboud, 1983, Effects of epidural anesthesia during labor on maternal plasma beta-endorphin levels, Anesthesiology, 59, 1, 10.1097\u002F00000542-198307000-00001\nAbboud, 1995, Desflurane: a new volatile anesthetic for cesarean section-maternal and neonatal effects, Acta Anaesthesiol Scand, 39, 723, 10.1111\u002Fj.1399-6576.1995.tb04159.x\nAbouleish, 1994, Rocuronium (Org 9426) for caesarean section, Br J Anaesth, 73, 336, 10.1093\u002Fbja\u002F73.3.336\nAdamsons, 1971, Production of fetal asphyxia in the rhesus monkey by administraron of catecholamines to the mother, Am J Obstet Gynecol, 109, 248, 10.1016\u002F0002-9378(71)90873-8\nAlahuhta, 1995, The effects of epidural ropivacaine and bupivacaine for cesarean section on uteroplacental and fetal circulation, Anesthesiology, 83, 23, 10.1097\u002F00000542-199507000-00004\nArora, 1992, Self-administered mixture of entonox and isoflurane in labour, Int J Obstet Gynecol, 1, 199\nBader, 1999, Clinical effects and maternal and fetal plasma concentrations of 0,5% epidural levobupivacaine versus bupivacaine for cesarean delivery, Anesthesiology, 90, 1596, 10.1097\u002F00000542-199906000-00015\nBelzarena, 1992, Clinical effects of intrathecally administered fentanyl in patients undergoing cesarean section, Anesth Analg, 74, 653, 10.1213\u002F00000539-199205000-00006\nBenhamou, 1998, Intrathecal clonidine and fentanyl with hyperbaric bupivacaine improves analgesia during cesarean section, Anesth Analg, 87, 609, 10.1213\u002F00000539-199809000-00022\nBerger, 1998, North American survey of the management of dural puncture occurring during labour epidural analgesia, Can J Anaesth, 45, 110, 10.1007\u002FBF03013247\nBernard, 1994, Préoxygénation avant induction pour césarienne, Ann Fr Anesth Réanim, 13, 2, 10.1016\u002FS0750-7658(94)80179-7\nBieniarz, 1968, Aortocaval compression by the uterus in late human pregnancy, Am J Obstet Gynecol, 100, 203, 10.1016\u002FS0002-9378(15)33723-6\nBjornestad, 1999, Epidural ropivacaine 7,5mg\u002FmL for elective caesarean section: a doubie-blind comparison of efficacy and tolerability with bupivacaine 5mg\u002FmL, Acta Anaesthesiol Scand, 43, 603, 10.1034\u002Fj.1399-6576.1999.430602.x\nBrock-Utne, 1981, Gastric and lower oesophageal sphincter (LOS) pressures in early pregnancy, Br J Anaesth, 33, 381, 10.1093\u002Fbja\u002F53.4.381\nBuggy, 1995, The space blanket and shivering during extradural analgesia in labour, Acta Anaesthesiol Scand, 39, 551, 10.1111\u002Fj.1399-6576.1995.tb04117.x\nBurrows, 1990, Thrombocytopenia at delivery: a prospective survey of 6 715 deliveries, Am J Obstet Gynecol, 162, 731, 10.1016\u002F0002-9378(90)90996-K\nButterworth, 1990, Pregnancy increases median nerve sensitivity to lidocaine, Anesthesiology, 72, 962, 10.1097\u002F00000542-199006000-00002\nCapogna, 1993, IV clonidine for post-extradural shivering in parturients: a preliminary study, Br J Anaesth, 71, 294, 10.1093\u002Fbja\u002F71.2.294\nCapogna, 1999, Relative potencies of bupivacaine and ropivacaine for analgesia in labour, Br J Anaesth, 82, 371, 10.1093\u002Fbja\u002F82.3.371\nCarstoniu, 1994, Nitrous oxide in early labor. Safety and anaigesic efficacy assessed by a double-blind, placebo-controlled study, Anesthesiology, 80, 30, 10.1097\u002F00000542-199401000-00008\nCartwright, 1983, Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans, Anesth Analg, 62, 966, 10.1213\u002F00000539-198311000-00002\nCesarini, 1990, Sprotte needle for intra thecal anesthesia for cesarean section: incidence of post dural puncture headache, Anaesthesia, 45, 656, 10.1111\u002Fj.1365-2044.1990.tb14392.x\nChristofides, 1982, Decreased plasma motilin concentrations in pregnancy, Br Med J, 285, 1453, 10.1136\u002Fbmj.285.6353.1453\nClaes, 1998, Clonidine added to bupivacaine-epinephrine-sufentanil improves epidural analgesia during childbirth [see comments], Reg Anesth Rain Med, 23, 540\nClark, 1991, Position change and central hemodynamic profile during normal third-trimester pregnancy and post-partum, Am J Obstet Gynecol, 164, 883, 10.1016\u002FS0002-9378(11)90534-1\nClayton, 1983, The incidence of Horner's syndrome during lumbar extradural for elective caesarean section and provision of analgesia during labour, Anaesthesia, 38, 583\nCollier, 1996, Why obstetric epidurals fail: a study of epidurograms, Int J Obstet Anesth, 5, 19, 10.1016\u002FS0959-289X(96)80070-7\nCollis, 1999, Comparison of midwife top-ups, continuous infusion and patient- controlled epidural analgesia for maintaining mobility after a low-dose combined spinal-epidural, Br J Anaesth, 82, 233, 10.1093\u002Fbja\u002F82.2.233\nColonna-Romano, 1992, Epidural test dose and intravascular injection in obstetrics: sensitivity, specificity, and lowest effective dose, Anesth Analg, 75, 372, 10.1213\u002F00000539-199209000-00009\nColonna-Romano, 1998, Tests to evaluate intravenous placement of epidural catheters in laboring women: a prospective clinical study, Anesth Analg, 86, 985, 10.1213\u002F00000539-199805000-00013\nColonna-Romano, 1996, Epinephrine-induced tachycardia is different from contraction-associated tachycardia in laboring patients, Anesth Analg, 82, 294\nCook, 1984, The influence on foetal outcome of maternal carbon dioxide tension at caesarean section under general anaesthesia, Anaesth Intensive Care, 12, 296, 10.1177\u002F0310057X8401200402\nCraft, 1983, Placental passage and uterine effects of fentanyl, Anesth Analg, 62, 894, 10.1213\u002F00000539-198310000-00007\nDahlgren, 1997, Intrathecal sufentanil, fentanyl, or placebo added to bupivacaïne for cesarean section, Anesth Analg, 85, 1288, 10.1213\u002F00000539-199712000-00020\nDann, 1987, Maternal and neonatal responses to alfentanil administered before induction of general anesthesia for cesarean section, Br J Anesth, 59, 1392, 10.1093\u002Fbja\u002F59.11.1392\nDatta, 1983, Differential sensitivities of mammalian nerve fibres during pregnancy, Anesth Analg, 62, 1070, 10.1213\u002F00000539-198312000-00004\nDatta, 1981, Neonatal effect of prolonged anesthetic induction for cesarean section, Obstet Gynecol, 58, 331\nDe Jong, 1994, Last round for a heavyweight?, Anesth Analg, 78, 3, 10.1213\u002F00000539-199401000-00002\nDe Simone, 1988, The chronotropic effect of isoproterenol is reduced in term pregnant women, Anesthesiology, 69, 626, 10.1097\u002F00000542-198810000-00034\nDennehy, 1998, Intrathecal catheter insertion during labour reduces the risk of post-dural puncture headache [see comments], Can J Anaesth, 45, 42, 10.1007\u002FBF03011991\nDickson, 1997, Comparison of single, end-holed and multi-orifice extradural catheters when used for continuous infusion of local anaesthetic during labour, Br J Anaesth, 79, 297, 10.1093\u002Fbja\u002F79.3.297\nDounas, 1994, Accidental subdural extra-arachnoid catheterization during epidural analgesia in obstetrics, Ann Fr Anesth Réanim, 13, 839, 10.1016\u002FS0750-7658(05)80921-9\nDounas, 1996, Maternal and fetal effects of adrenaline with bupivacaine (0,25 %) for epidural analgesia during labour, Eur J Anaesthesiol, 13, 594, 10.1097\u002F00003643-199611000-00009\nEbner, 1960, Influence of postspinal hypotension on the fetal electrocardiogram, Am J Obstet Gynecol, 80, 569, 10.1016\u002FS0002-9378(16)36516-4\nEckstein, 1974, Aortocaval compression and uterine displacement, Anesthesiology, 40, 92, 10.1097\u002F00000542-197401000-00025\nEisenach, 1994, Is ST segment depression of the electrocardiogram during cesarean section merely due to cardiac sympathetic block?, Anesth Analg, 78, 287, 10.1213\u002F00000539-199402000-00015\nEvans, 1980, Plasma cholinesterase changes during pregnancy, Anaesthesia, 35, 65, 10.1111\u002Fj.1365-2044.1980.tb03878.x\nFagraeus, 1983, Speed of epidural analgesia in early pregnancy, Anesthesiology, 58, 184, 10.1097\u002F00000542-198302000-00015\nFalconer, 1982, Plasma noradrenaline levels during labour: influence of elective lumbar epidural blockade, Anaesthesia, 37, 416, 10.1111\u002Fj.1365-2044.1982.tb01151.x\nFilos, 1992, Intrathecal clonidine as a sole analgesic for pain relief aftercesarean section, Anesthesiology, 77, 267, 10.1097\u002F00000542-199208000-00008\nFrank, 1987, Nalbuphine for obstetric analgesia, Anaesthesia, 42, 697, 10.1111\u002Fj.1365-2044.1987.tb05313.x\nGambling, 1995, Use of sevoflurane during elective cesarean birth: a comparison with isoflurane and spinal anesthesia, Anesth Analg, 81, 90, 10.1213\u002F00000539-199507000-00018\nGautier, 1999, A Double-blind comparison of 0,125 % ropivacaine with sufentanil and 0,125 % bupivacaine with sufentanil for epidural labor analgesia, Anesthesiology, 90, 772, 10.1097\u002F00000542-199903000-00020\nGepts, 1986, Pharmacokinetics and placental transfer of intravenous and epidural alfentanilin parturient women, Anesth Analg, 65, 1155, 10.1213\u002F00000539-198611000-00010\nGerbasi, 1990, Changes in hemostasis activity during delivery and the immediate postpartum period, Am J Obstet Gynecol, 162, 1158, 10.1016\u002F0002-9378(90)90006-S\nGolub, 1988, Disposition of intrapartum narcotic analgesics in monkeys, Anesth Analg, 67, 637, 10.1213\u002F00000539-198807000-00005\nGreeley, 1987, Sufentanil pharmacokinetics in pediatric cardiovascular patients, Anesth Analg, 66, 1067, 10.1213\u002F00000539-198711000-00001\nGriffin, 1995, Extradural anaesthesia for cesarean section: a double-blind comparison of 0,5% ropivacaïne and 0,5% bupivacaine, Br J Anaesth, 74, 512, 10.1093\u002Fbja\u002F74.5.512\nGuillonneau, 1990, Perinatal adverse effects of Nalbuphine given during parturition, Lancet, 335, 1588, 10.1016\u002F0140-6736(90)91411-3\nHamber, 1999, Intrathecal lipophilic opioids as adjuncts to surgical spinal anesthesia, Reg Anesth Pain Med, 24, 255, 10.1097\u002F00115550-199924030-00015\nHamza, 1992, Neonatal pattern of breathing during active and quiet sleep after maternal administraron of meperidine, Pediatr Res, 32, 412, 10.1203\u002F00006450-199210000-00009\nHodgkinson, 1978, Neonatal neurobehavioral tests following cesarean section under general and spinal anesthesia, Am J Obstet Gynecol, 132, 670, 10.1016\u002F0002-9378(78)90862-1\nHool, 1992, Retained epidural catheter fragment [letter], Anaesth Intensive Care, 20, 393\nHunt, 1989, Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery, Anesthesiology, 71, 535, 10.1097\u002F00000542-198910000-00009\nIrestedt, 1997, Ropivacaine 7,5mg\u002FmL for elective caesarean section: a clinical and pharmacokinetic comparison between 150mg and 187,5mg, Acta Anaesthesiol Scand, 41, 1149, 10.1111\u002Fj.1399-6576.1997.tb04857.x\nKambam, 1986, The effect of normal and preeclamptic pregnancies on the oxyhemoglobin dissociation cune, Anesthesiology, 65, 426, 10.1097\u002F00000542-198610000-00014\nKestin, 1991, Spinal anesthesia in obstetrics, Br J Anaesth, 66, 596, 10.1093\u002Fbja\u002F66.5.596\nKierkegaard, 1983, Incidence and diagnosis of deep vein thrombosis associated with pregnancy, Acta Obstet Gynecol Scand, 62, 239, 10.3109\u002F00016348309155799\nKleiman, 1991, Patient-controlled analgesia (PCA) using fentanyl in a parturient with a platelet function abnormality, Can J Anaesth, 38, 489, 10.1007\u002FBF03007585\nKnusden, 1997, Central venous and cardiovascular effect of IV infusions of ropivacaine, bupivacaine and placebo volunteers, Br J Anaesth, 78, 507, 10.1093\u002Fbja\u002F78.5.507\nKuhnert, 1985, Effect of low dose meperidine on neonatal behavior, Anesth Analg, 64, 335, 10.1213\u002F00000539-198503000-00006\nLeighton, 1986, Succinylcholine pharrnacodynarnics in peripartum patients, Anesthesiology, 64, 202, 10.1097\u002F00000542-198602000-00012\nLeighton, 1987, Limitation of epinephrine as a marker of intravascular injection in laboring women, Anesthesiology, 66, 688, 10.1097\u002F00000542-198705000-00017\nLynn, 1987, Morphine pharmacokinetics in early infancy, Anesthesiology, 66, 136, 10.1097\u002F00000542-198702000-00005\nMacfie, 1991, Gastric emptying during pregnancy, Br J Anaesth, 67, 54, 10.1093\u002Fbja\u002F67.1.54\nMalloy, 1989, Increasing cesarean section rates in very low birth weight infants. Effects on outcome, JAMA, 262, 1475, 10.1001\u002Fjama.1989.03430110065029\nMcLeod, 1985, Self administered isoflurane in labour, Anaesthesia, 40, 424, 10.1111\u002Fj.1365-2044.1985.tb10841.x\nMorton, 1997, Ropivacaine 0,75 % for extradural anaesthesia in elective caesarean section: an open clinical and pharmacokinetic study in mother and neonate, Br J Anaesth, 79, 3, 10.1093\u002Fbja\u002F79.1.3\nMyers, 1979, Use of sedative, anaigesic, and anesthetic drugs during labor and delivery: bane or boon?, Am J Obstet Gynecol, 133, 83, 10.1016\u002F0002-9378(79)90417-4\nNoble, 1991, Adrenaline, fentanyl or adrenaline and fentanyl as adjuncts to bupivacaine for extradural anesthesia in elective cesarean section, Br J Anaesth, 66, 645, 10.1093\u002Fbja\u002F66.6.645\nNorris, 1998, Labor epidural analgesia without an intravascular «test dose», Anesthesiology, 88, 1495, 10.1097\u002F00000542-199806000-00012\nNorris, 1989, Denitrogenation in pregnancy, Can J Anaesth, 36, 523, 10.1007\u002FBF03005379\nOlofsson, 1998, Obstetric outcome following epidural analgesia with bupivacaine-adrenaline 0,25 % or bupivacaine 0,125 % with sufentanil: a prospective randomized controlied study in 1 000 parturients [see comments], Acta Anaesthesiol Scand, 42, 284, 10.1111\u002Fj.1399-6576.1998.tb04918.x\nOrmezzano, 1990, Prévention de la pneumo-pathie d'inhalation en anesthésie obstétricale parl'association effervescente cimétidine-citrate de sodium, Ann Fr Anesth Réanim, 9, 285, 10.1016\u002FS0750-7658(05)80188-1\nPalahniuk, 1974, Pregnancy decreases the requirements for inhaled anesthetic agents, Anesthesiology, 41, 82, 10.1097\u002F00000542-197407000-00021\nPerreault, 1992, Maternal inspired oxygen concentration and fetal oxygenation during caesarean section, Can J Anaesth, 39, 155, 10.1007\u002FBF03008647\nPoblete, 1999, Efficacy of three test doses to detect epidural catheter misplacement, Can J Anaesth, 46, 34, 10.1007\u002FBF03012511\nPolley, 1998, Dose-dependent reduction of the minimum local analgesic concentration of bupivacaine by sufentanil for epidural analgesia in labor, Anesthesiology, 89, 626, 10.1097\u002F00000542-199809000-00011\nPnce, 1991, Extending epidural blockade for emergency caesarean section. Evaluation of 2 % lignocaine with adrenaline, Int J Obstet Anesth, 1, 13, 10.1016\u002F0959-289X(91)90024-K\nRamanathan, 1982, Oxygen transfert from mother to fetus during cesarean section under epidural anesthesia, Anesth Analg, 61, 576, 10.1213\u002F00000539-198207000-00005\nRamanathan, 1988, Vasopressor therapy for hypotension due to epidural anesthesia for cesarean section, Acta Anesthesiol Scand, 32, 559, 10.1111\u002Fj.1399-6576.1988.tb02786.x\nRamanathan, 1983, Maternal and fetal effects of prophylactic hydration with cristalloids or colloids before epidural anesthesia, Anesth Analg, 62, 673, 10.1213\u002F00000539-198307000-00009\nRavindran, 1989, Postpartum headache following regional analgesia: a symptom of cerebral venousthrombosis, Can J Anaesth, 36, 705, 10.1007\u002FBF03005426\nRayburn, 1989, Fentanyl citrate analgesia during labor, Am J Obstet Cynecol, 161, 202, 10.1016\u002F0002-9378(89)90266-4\nRayburn, 1989, Randomized comparison of meperidine and fentanyl during labor, Obstet Gynecol, 74, 604\nRolbin, 1988, Epidural anesthesia in pregnant patients with low platelet counts, Obstet Gynecol, 71, 918\nRussell, 1996, Patient-controlled analgesia with morphine and droperidol following cesarean section under spinal anaesthesia, Acta Anaesthesiol Scand, 40, 600, 10.1111\u002Fj.1399-6576.1996.tb04495.x\nRussell, 1996, Long-term backache after childbirth: prospective search for causative factors [see comments], Br Med J, 312, 1384, 10.1136\u002Fbmj.312.7043.1384a\nSamsoon, 1987, Difficult tracheal intubation: a retrospective study, Anaesthesia, 42, 487, 10.1111\u002Fj.1365-2044.1987.tb04039.x\nSantos, 1989, Does pregnancy alter the systemic toxicity of local anesthetics?, Anesthesiology, 70, 991, 10.1097\u002F00000542-198906000-00018\nShankar, 1987, Physiological dead space during general anesthesia for cesarean section, Can Anaesth Soc J, 34, 373, 10.1007\u002FBF03010136\nSinclair, 1965, Intoxication of the fetus by a local anesthetic, a newly recognized complication of maternal caudal anesthesia, N Engl J Med, 273, 1173, 10.1056\u002FNEJM196511252732201\nSkoldefors, 1998, Intracranial subdural haematoma complicates accidental dural tap during labour, Eur J Obstet Gynecol Reprod Biol, 81, 119, 10.1016\u002FS0301-2115(98)00157-2\nSprigge, 1999, The use of sumatriptan in the treatment of postdural puncture headache after accidental lumbar puncture complicated a blood patch procedure [letter], Anaesthesia, 54, 95, 10.1046\u002Fj.1365-2044.1999.0759q.x\nSteinberg, 1989, Epidural sufentanil for analgesia for labor and delivery, Reg Anesth, 14, 225\nThornton, 1976, A comparison of the effect of extradural and parenteral analgesia on maternal plasma cortisol concentrations during labour and the puerperium, Br J Obstet Gynaeco, 83, 631, 10.1111\u002Fj.1471-0528.1976.tb00901.x\nTournaire, 1980, Influence de la péthidine sur l'activité utérine et la dilatation cervicale lors du travail spontané, J Gynécol Obstét Biol Reprod, 9, 261\nWilliams, 1998, Efficiency of epidural blood patches in the obstetrics [letter, comment], Can J Anaesth, 45, 1031, 10.1007\u002FBF03012313\nWittes, 1990, Exogenous opiods in human breast milk and acute neonatal neurobehavior: a preliminary study, Anesthesiology, 73, 864, 10.1097\u002F00000542-199011000-00012\nWysowski, 1998, Spinal and epidural hematoma and low molecular weight heparin, N Engl J Med, 338, 1774, 10.1056\u002FNEJM199806113382415\nYentis, 1997, Epidural blood patch for atypical headache following obstetric epidural analgesia, Anaesthesia, 52, 62, 10.1111\u002Fj.1365-2044.1997.010-az010.x\nYounker, 1986, Massive air embolism during cesarean section, Anesthesiology, 65, 77, 10.1097\u002F00000542-198607000-00013\nYucel, 1999, Intravenous administration of caffeine sodium benzoate for postdural puncture headache, Reg Anesth Pain Med, 24, 51, 10.1097\u002F00115550-199924010-00010\nZakowski, 1993, Electrocardiographic changes during cesarean section A cause for concern, Anesth Analg, 76, 162, 10.1213\u002F00000539-199301000-00027",{"ES":1018},"Analgesia y anestesia en el parto",{"VOID":1020},"10.1016\u002Fs1283-081x(02)71905-x","Author affiliation is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X0271905X",[1024],{"id":1025,"sortIndex":18,"researcher":17,"roles":1026,"affiliations":1027,"properties":1028},"dbf994a4-2195-48b7-b05b-c7ade54e7178",[48],[],{"title":1029},{"VI":1030},"Gilles Boulay",{"url":1022,"publisher":1032,"properties":1040},{"id":6,"createTime":7,"updateTime":7,"relativeEntities":1033,"slug":9,"properties":1034,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":1037,"manageAffiliations":1038,"indexDatabases":1039,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":1035,"title":1036},{"VOID":12},{"EN":14},[],[],[],{"volume":1041,"pages":1043},{"VOID":1042},"38",{"VOID":486},"2002-01-01",2002]